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A Opening remark
This thesis was performed in a laboratory that focuses on B cell development and
function in vivo and has developed conditional gene targeting as a tool to analyze
gene function in the murine immune system. I completed two independent projects
that reflect both the biological and technical scope of the lab. In the first project I
generated a mouse strain that carries an immunoglobulin (Ig) l1 light chain gene
insertion. I analyzed the impact of a pre-rearranged l1 light chain on Igk
rearrangement and Igk versus Igl isotype exclusion as well as the fate of B cells that
escape isotype exclusion and consequently express two distinct B cell receptor
specificities. The second project describes two novel approaches in conditional gene
targeting: one allows unidirectional genetic inversion in mice and the other involves
siRNA-mediated inducible gene inactivation in ES cells. Both methods are useful
additions to the toolbox of mouse genetics and will hopefully find a broad range of
biological applications.
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B Part I) B cell development and function in mice
with a targeted l1 light chain gene insertion
B 1  INTRODUCTION
B lymphocyte development is a highly regulated process that leads to the generation
of a diverse repertoire of B cell receptor (BCR) antigen specificities. Multiple alleles
can potentially contribute to the formation of the BCR. However, a tightly controlled
sequence of chromatin remodeling and somatic recombination events ensures that any
given B cell expresses a single BCR specificity, which can then be recruited into an
antigen-specific immune response.
B 1.1 The B cell antigen receptor
The BCR consists of two identical immunoglobulin heavy (IgH) chains and two
identical Ig light (IgL) chains, which are covalently linked by disulfide bonds, and are
brought to the cell surface only in combination with the signal transducing Iga/Igb
heterodimer. Each Ig molecule has a constant (C) and a variable (V) region. The
variable regions of IgH and IgL chains contain hypervariable regions, which form the
antigen binding sites of the BCR and are therefore termed complementarity
determining regions (CDRs). The constant regions define the isotype of the Ig
molecule and are subdivided into Ck and Cl in the case of IgL and Cm, Cd, Cg1,
Cg2a, Cg2b, Cg3, Ce and Ca in the case of IgH. While no functional differences have
been reported for Ck and Cl, different IgH constant regions have different signaling
properties when membrane-bound and mediate distinct effector functions when
secreted. Switch from IgM to IgG, IgA or IgE is an irreversible somatic
recombination event termed Ig class switch recombination. Expression of IgD, on the
other hand, is the consequence of alternative splicing and can therefore occur together
with IgM expression. Alternative splicing is further responsible for the generation of
the secreted form of Ig molecules (for reviews see (Manis et al., 2002; Rajewsky,
1996)).
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B 1.2 B cell development
In the mouse, B cells develop in the fetal liver during embryogenesis and in the bone
marrow after birth. IgH and IgL chains are assembled from various gene segments by
tightly regulated somatic recombination events (see chapter 1.3) at consecutive
developmental stages during B cell development. These stages can be distinguished
by differential expression of surface antigens. IgH rearrangements occur in pro B cells
(B220low, CD43+, CD25-, Ig-) and, if productive, promote a phase of proliferative
expansion and subsequent IgL rearrangement in pre B cells (B220low, CD43-, CD25+,
Ig-). Upon productive IgL rearrangement, B cells express IgM on the cell surface and
are considered immature B cells (B220low, CD43-, CD25-, IgM+) until they complete
maturation with co-expression of IgD (reviewed in (Hardy and Hayakawa, 2001;
Rolink and Melchers, 1996)). Mature B cells can be subdivided into several,
functionally and phenotypically distinct subpopulations: follicular (FO) B cells or B2
cells, B1 cells, marginal zone (MZ) B cells, plasma cells and memory B cells.
FO B cells are IgM+, IgDbright and are typically long-lived with life spans ranging
from a few weeks to several months and possibly years (Fulop et al., 1983; Forster
and Rajewsky, 1990; Osmond, 1993; Hao and Rajewsky, 2001). FO B cells compose
the vast majority of the peripheral B cell pool and recirculate through all lymphatic
organs. Upon antigen encounter, they become activated and undergo further
differentiation into plasma cells or memory B cells. While plasma cells can form in
response to both T cell dependent (TD) and T cell independent (TI) antigens, the
generation of memory B cells is normally dependent on T cell help and takes place in
specialized morphological structures termed germinal centers (reviewed in
(MacLennan, 1994)). Memory B cells have generally undergone class-switch
recombination, are long-lived and their survival appears to be independent of cognate
antigen ( Schittek and Rajewsky, 1990; Maruyama et al., 2000). Memory B cells are
further characterized by somatically mutated BCRs, which have been selected for
optimal affinity to the immunizing antigen following somatic hypermutation in
germinal centers. This process is termed affinity maturation and is driven by BCR-
antigen interaction (reviewed in (Diaz and Casali, 2002)). A subset of memory B cells
terminally differentiates into antibody-secreting plasma cells, which preferentially
home to the bone marrow where they were shown to persist for several months or
longer (Benner et al., 1981; Manz et al., 1997). Similar to memory B cells, long-lived
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plasma cells appear to be maintained in an antigen-independent manner (Manz et al.,
1998; Slifka et al., 1998). While long-lived plasma cells represent a small, specialized
plasma cell subset that is thought to confer long term protection against the
immunizing antigen, most plasma cells form early during an immune response in
order to provide rapid protection against the invading pathogen. Such extrafollicular
plasma cells are generated during both TD and TI immune responses in the medullary
cords of lymph nodes and in foci in the red pulp of the spleen. The majority of these
cells survive for approximately three days. Some were, however, shown to become
long-lived and are thought to reside either in the splenic red pulp or in the bone
marrow (Sze et al., 2000). Extrafollicular plasma cells can be class-switched, but do
normally not show signs of somatic hypermutation (reviewed in (Cyster, 2003;
MacLennan et al., 2003)).
Another important source of serum Ig are B1 cells, which were first identified by
Hayakawa et al. (Hayakawa et al., 1983) as a B cell subset that expresses the T cell
marker Ly-1/CD5 (Hayakawa et al., 1983). B1 cells are generated during early B cell
development, mainly from fetal liver precursor B cells and are activated in a
polyclonal, T cell independent fashion (reviewed in (Su and Tarakhovsky, 2000)).
Activation can be triggered by self-antigen and activated B1 cells are therefore
considered a major source of natural autoantibodies. B1 cell derived serum Ig is
predominantly of the µ and g3 isotypes (reviewed in (Hayakawa and Hardy, 2000)).
B1 cells are generally Mac1+, CD43+, IgMbright and IgDlow, have self-renewing
capacity and are predominantly located in the peritoneum. It is still unclear whether
these cells represent a distinct B cell lineage or whether B1 and B2 B cells are derived
from the same precursor cells. The observation that recognition of auto-antigen in the
bone marrow favored the generation of B1 cells indicates that ligand-BCR interaction
may play a role in B1 lineage decision. ((Hayakawa et al., 1999; Hayakawa et al.,
2003)). Moreover, certain antigen receptor specificities appear to preferentially direct
B1 cell development (Arnold et al., 1994; Lam and Rajewsky, 1999).
MZ B cells represent a similarly specialized B cell subset and are found exclusively in
the spleen within the marginal zones that surround B cell follicles. MZ B cells are
defined as IgMhigh, IgDlow, CD21high and CD23low. In contrast to B2 cells, MZ B cells
and B1 cells have the unique capacity to generate effector cells in early stages of the
immune response, mostly against TI antigens, and are thus thought to be the first line
of defense for antigens that are scavenged efficiently in either the peritoneum or the
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marginal zone (Martin and Kearney, 2000a; Martin et al., 2001). The generation of
MZ B cells was shown to depend on several BCR-associated signaling molecules and
was further suggested to be influenced by the BCR specificity (Martin and Kearney,
2000b). Thus, like in B1 cell formation, antigenic selection might play a role in MZ B
cell differentiation.
While the role of BCR-ligand interaction in the generation and maintenance of
individual B cell subsets is still poorly understood, it is clear that surface expression
of the BCR is essential for the survival of most B cell subsets (Lam et al., 1997). The
requirement of BCR expression in the memory B cells subset and in plasma cells is,
however, still controversial.
B 1.3 V(D)J recombination
To guarantee a diverse B cell repertoire, which is able to respond to an unlimited
spectrum of foreign antigens, vertebrates have evolved a combinatorial approach to
assemble immunoglobulin variable regions from a variety of distinct gene segments.
In mice, these gene segments comprise several hundred variable (V), 14 diversity (D)
and 4 joining (J) segments in the IgH locus, ~100 V and 4 functional J segments in
the Igk locus and 3 V and 3 functional J segments in the Igl locus (Figure 1). V, D
and J segments are combined during early lymphocyte differentiation by a common
V(D)J recombinase that consists of the Recombination Activating Gene products
RAG1 and RAG2 (Oettinger et al., 1990; Schatz et al., 1989) and recognizes
conserved recombination signal sequences (RSS) flanking the V, D and J segments.
Imprecise joining and N nucleotide addition mediated by Terminal deoxynucleoside
transferase (TdT) represent an additional means of variable region diversification
during V(D)J recombination. IgH rearrangement can occur on two IgH alleles, while
Ig light chains can be generated from two Igl and two Igk alleles. Any given B cell
expresses only one of the two allelic IgH loci and one of the multiple IgL loci as
proteins and thus carries an Ig molecule of single specificity. This phenomenon is
termed allelic or (k versus l) isotype exclusion (reviewed in (Bassing et al., 2002)).
While allelic exclusion at the IgH loci is extremely efficient and B cells that express
two distinct IgH chains are virtually absent, allelic and isotype exclusion at the IgL
loci appear to be less stringent as 1-2% of mature B cells were shown to express more
than one light chain in mice (Casellas et al., 2001; Gollahon et al., 1988). The reason
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for this discrepancy is unknown. It may, however, be related to the fact that pre B
cells can undergo several rounds of IgL rearrangement in order to alter the specificity
of the BCR. This process is termed receptor editing and is discussed in further detail
in chapter 1.6.
Figure 1. Genomic map of the mouse Ig loci. Exons are shown as rectangles and comprise
variable (V), diversity (D), joining (J) and constant region (C) gene segments. Enhancers are
depicted as ovals; iE, intronic enhancer; 3’E, e’ enhancer. Map is not drawn to scale.
B 1.4 Ig locus accessibility
Generally, tissue-specific and developmentally regulated Ig rearrangement is ensured
by Ig locus-specific enhancers, which render the Ig locus accessible for DNA binding
proteins such as transcription factors and the RAG1/RAG2 complex. Ig loci normally
harbor two types of enhancers: intronic enhancers, which are located in the intron
between the last J exon and the first C exon, and 3’ enhancers, which can be found 3’
of the last C exon (reviewed in (Chen and Alt, 1993; Gorman and Alt, 1998)).
However, no intronic enhancers have been identified in the Igl locus. Germline
transcripts from unrearranged Ig loci that initiate upstream of V, D or J segments can
be detected in B cell progenitors that are in the process of rearranging the respective
Ig loci (Corcoran et al., 1998; Schlissel et al., 1991; Yancopoulos and Alt, 1985).
Recently, Nussenzweig and colleagues showed that the level of Vk germline
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transcription needs to exceed a certain threshold before a Vk segment becomes
susceptible to rearrangement, thus providing evidence for a functional association of
germline transcription with rearrangement (Casellas et al., 2002). Moreover, the
intronic Igk enhancer (iEk) and the 3’ Igk enhancer (3’Ek) were found to be
important for Igk transcription and rearrangement (Gorman et al., 1996; Takeda et al.,
1993; Xu et al., 1996; Meyer and Neuberger, 1989). Mice that lack both enhancers do
not undergo detectable Igk rearrangements and lack of either 3’Ek or iEk alone
causes a quantitatively comparable decrease in Igk germline transcription and Igk
rearrangements (Inlay et al., 2002; Gorman et al., 1996). The introduction of a
phosphoglycerol kinase (PGK)-promoter driven neoR gene 5’ of the Jl1 segment led
to a substantial increase in both Jl1 germline transcription and Vl1Æ Jl1
rearrangement and thus demonstrates a similar linkage between the two processes in
the Igl locus (Sun and Storb, 2001).
Besides cis-regulatory elements, epigenetic DNA modifications were shown to play
an important role in the regulation of Ig rearrangement. These modifications are
inheritable changes in chromatin structure that do not affect the genetic information
itself. Epigenetic changes include histone modifications, such as acetylation and
methylation, as well as DNA methylation. Methylation of CpG DNA islands is now
recognized to be a main player in establishing a silent chromatin state and acts
through the recruitment of proteins that modify nucleosomes, such as methyl-CpG
binding proteins and histone deacetylases (reviewed in (Jaenisch and Bird, 2003)). It
has been demonstrated many years ago, that DNA undermethylation correlates with
Ig expression and B cell differentiation (Storb and Arp, 1983). Recently,
Mostoslavsky et al. found that the initiation of Igk rearrangements coincides with
demethylation in the Jk region and that only one of the two Igk alleles is subject to
demethylation in the majority of B cells (Mostoslavsky et al., 1998). Interestingly, Igk
germline transcription seems to be unaffected by DNA methylation since it was
shown to occur in a biallelic fashion (Singh et al., 2003). Demethylation and germline
transcription may therefore be independently required to mark an Ig allele for
rearrangement and RAG1/2 accessibility. Further chromosome modifications that
have been correlated with Ig rearrangement include histone hyperacetylation (Johnson
et al., 2003; McMurry and Krangel, 2000) and asynchronous chromosomal
replication, which is established during emryogenesis and appears to ‘mark’ one
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chromosome for rearrangement by an as yet unknown mechanism (Mostoslavsky et
al., 2001).
1.5 Regulation of IgL rearrangement
Despite extensive research on IgL locus accessibility and rearrangement, the
developmental regulation of IgL rearrangement is still poorly understood. In mice, B
cells that express Igk are 15-20 times more frequent than those expressing Igl. In
humans, the frequencies of k and l expressing B cells are similar, yet in both mice
and humans, k+ B cells generally carry the Igl locus in germline configuration, while
the vast majority of l+ B cells has inactivated its Igk loci by either non-functional
VkJk joints or deletion of the k constant region (Ck) gene (Brauninger et al., 2001;
Hieter et al., 1981; Takeda et al., 1993; Yamagami et al., 1999). Ck deletion is the
consequence of a recombination event that occurs between an RSS located either in
the Jk-Ck intron or at the 3’ end of a non-rearranged Vk gene and a downstream
“rearranging” sequence called RS in mice (Durdik et al., 1984) and k-deleting
element (Kde) in humans (Siminovitch et al., 1985). However, in some cells, IgL
rearrangement is initiated at the Igl locus as shown by a small fraction of k+ B cells
that carry non-functional Igl rearrangements (Coleclough et al., 1981; Yamagami et
al., 1999; Zou et al., 1993).
An ordered and a stochastic model were put forward to explain these findings (Hieter
et al., 1981; Coleclough et al., 1981). The ordered model proposes regulated opening
of IgL loci with Igk being accessible for rearrangements prior to Igl. The stochastic
model predicts that both IgL loci are accessible at the same time with the probability
of rearrangements being higher for Igk than for Igl (reviewed in (Gorman and Alt,
1998)). The analyses of several mouse mutants with impaired Igk rearrangement
and/or expression demonstrated, however, that inactivation of the Igk locus causes a
tenfold increase in l+ B cells and were therefore incosistent with either of the two
models. Inactivation of Igk was achieved by replacing the intronic k enhancer (iEk)
(Takeda et al., 1993), the Ck gene segment (Zou et al., 1993) or Jk and Ck gene
segments (Chen et al., 1993) with a neoR gene. While the former manipulation causes
complete silencing of Vk’Jk rearrangements, the two latter mutations exert only a
mild effect on Igk rearrangement but abolish expression of a functional k light chain.
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The drastic increase in l-expressing B cells in these mice led to the proposal of
negative regulatory elements in the germline Igk locus that would actively suppress l
rearrangements and be artificially disrupted in the mutant alleles. In wild-type (WT)
mice, inactivation of such elements upon Igk rearrangement was suggested to
increase the probability of Igl rearrangements (Chen et al., 1993; Zou et al., 1993).
Taken together, current knowledge suggests that Igk is generally rearranged prior to
Igl and that this phenomenon may be controlled by an Igk-derived negative
regulatory signal that interferes with Igl rearrangement and/or transcription. Whether
or not the unrearranged Igk locus negatively regulates the transcriptional accessibility
of Igl is investigated in the work presented here.
B 1.6 B cell tolerance and receptor editing
The random assembly of a diverse BCR repertoire imposes a major problem on the
immune system in that self-reactive receptor specificities have to be eliminated. In
order to achieve ‘tolerance’ to self-antigens, auto-reactive B cells can be deleted,
functionally silenced in a state called ‘anergy’ or undergo a process known as receptor
editing (reviewed in (Buhl et al., 2000)). Receptor editing describes the alteration of a
given BCR specificity via continuing Ig rearrangements. The fraction of immature B
cells that undergo editing in wild-type mice was estimated to be between 20% to 30%
(Casellas et al., 2001). In humans, 55-75% of all antibodies that are expressed in
immature B cells were shown to be autoreactive, and receptor editing appears to play
an important role in the removal of these cells (Wardemann et al., 2003). Thus,
receptor editing represents a major mechanism of B cell tolerance. The Igk locus
allows multiple rounds of VkÆJk rearrangements (see Figure 1) and is consequently
the most frequently edited Ig locus. Ongoing Igk  rearrangements lead to the
inactivation of previous VJk joints and can ultimately inactivate the respective Igk
allele by RS recombination (see above). These cells can be rescued by Igl
rearrangements and the generation of l+ B cells has therefore been directly correlated
with receptor editing (Retter and Nemazee, 1998). Whether l+ B cells themselves
undergo receptor editing has however not yet been conclusively demonstrated. The
unique composition of the Igl locus does not allow the deletion of previously
rearranged Igl joints (see Figure 1) and editing of l+ B cells is expected to yield B
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cells that express two distinct Ig light chains. As mentioned earlier, k/l double
positive B cells can be generated at very low numbers and are a potential threat to the
immune system, since specific immune responses may activate these cells and lead to
the production of unspecific and potentially autoreactive ‘bystander’ Igs (Li et al.,
2002). Both the extent of receptor editing in l1+ B cells and the fate of B cells, which
express two distinct BCR specificities as a consequence of receptor editing, are
addressed in this thesis.
B 1.7 Objectives of this study
In humans and mice, Igk  rearrangements occur more frequently than Igl
rearrangements and previous results suggested that the unrearranged Igk locus
negatively regulates Igl transcription and/or rearrangement. The aim of my thesis was
to test whether the unrearranged Igk locus does indeed provide a negative regulatory
signal that interferes with Igl expression. I therefore generated a mouse mutant, in
which a VJl1-joint has been inserted into its physiological position in the Igl locus,
and analyzed its impact on Igk rearrangement and isotype exclusion. I also addressed
the fate of B cells that escape isotype exclusion in this mouse model via receptor
editing in l+ B cells. Specifically, I analyzed how the expression of two distinct BCR
specificities affects B cell development and B cell activation upon antigen encounter.
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B 2 MATERIALS AND METHODS
B 2.1 Molecular Biology
B 2.1.1 Competent cells and iolation of plasmid DNA
Competent Escherichia coli DH5a cells were prepared as described by Inoue et al.
(Inoue et al., 1990) and used in heat shock transformations of plasmid DNA. DNA
ligation was performed using NEB T4 Ligase or NEB Quick Ligase according to the
maufacturer’s protocol. Plasmid DNA was isolated from transformed Escherichia coli
DH5a bacteria by alkaline lysis (Birnboim, 1983) according to the protocol of (Zhou
et al., 1990). Plasmid DNA of a higher purity was obtained with QIAGEN columns
(QIAGEN) following the supplier's instructions.
B 2.1.2 Molecular cloning
Molecular cloning was performed according to standard protocols (Sambrook et al.,
1989). Enzymes were obtained from the following companies: Roche, GIBCO-BRL,
New England Biolabs (NEB), Stratagene and Takara.
B 2.1.3 Isolation of genomic DNA from ES cells and mouse organs
Cells were lysed over night at 56°C in lysis buffer (100 mM Tris-HCl, pH 8.5; 5 mM
EDTA; 200 mM NaCl; 0.2% SDS; 500 mg/ml Proteinase K). Subsequently, DNA
was precipitated by the addition of an equal volume of isopropanol. DNA was
pelleted by centrifugation, washed in 70% EtOH and resuspended in double distilled
(dd) H2O. To extract DNA from ES cell clones, that were grown in 96-well tissue
culture dishes, plates were treated according to the protocol of (Pasparakis and
Kollias, 1995). Mouse tissue was incubated for 6 h to o/n at 56°C in lysis buffer.
Undissolved debris was pelleted and the supernatant was mixed with an equal volume
of isopropanol to precipitate the DNA. The DNA was washed in 70% EtOH, dried
and resuspended in ddH2O.
B 2.1.4 Agarose gel electrophoresis and DNA gel extraction
Separation of DNA fragments by size was achieved by electrophoresis in agarose gels
(0.7% - 2.5%; 1 x TAE (Sambrook et al., 1989); 0.5 mg/ml ethidium bromide). DNA
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fragments were isolated from agarose gel slices using QIAquick Gel Extraction Kit
(QIAGEN) according to the manufacturer's instructions. Size markers for agarose gel
electrophoresis were obtained from GIBCO-BRL (1 kb marker) and NEB (2-Log
ladder).
B 2.1.5 DNA sequencing
DNA fragments were sequenced with the 'Taq DyeDeoxyTerminator Cycle
Sequencing Kit' (Applied Biosystems), which is a modification of the Sanger et al.
Protocol (Sanger et al., 1977). The fluorescently labelled DNA pieces were separated
and analysed with ABI373A and ABI377 systems (Applied Biosystems) with the help
of S. Willms.
B 2.1.6 Purification of RNA and reverse transcription
Total RNA was isolated using TRIzol (Invitrogen) following the manufacturer’s
protocol. All RNA work was done using DEPC-treated H2O. cDNA was synthesized
from 20,000 cells using oligo-dT primer and Thermoscript RT-PCR System
(Invitrogen) according to the manufacturer’s instructions. 1/10 of the cDNA template
and serial dilutions thereof were subjected to PCR (see chapter 2.1.8)
B 2.1.7 Quantification of nucleic acids
The concentration of nucleic acids was determined by measuring the absorption of the
sample at 260 nm and 280 nm in a spectrophotometer (Pharmacia). An OD260 of 1
corresponds to approximately 50 mg/ml for double stranded DNA or 40 mg/ml for
RNA and single stranded DNA. Purity of nucleic acids can be estimated by the ratio
OD260/OD280, pure preparations of DNA and RNA show a ratio of 1.8 and 2.0,
respectively.
B 2.1.8 Polymerase chain reaction (PCR)
PCR (Mullis and Faloona, 1987; Saiki et al., 1985) was used to genotype mice for the
presence of the targeted allele or the respective wild-type allele, and to amplify
fragments for sequencing, molecular cloning or the generation of Southern blot
probes. In addition, PCR served to amplify cDNA for analytic purposes. Reactions
were performed either in PTC-200 machines (MJ-Research) or Trio-thermocyclers
(Biometra).
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PCR reactions were generally performed in a total volume of 50 µl using the
following reaction mix: 25 pmol of each primer, 0.5 U of Thermus aquaticus (Taq)
DNA polymerase (GIBCO-BRL or Eppendorf), 10 mM dNTPs (Pharmacia), 10 mM
Tris-HCl pH 8.3, 50 mM KCl, 1.5 mM MgCl2, 10-100 ng template DNA.
Amplification started with denaturation for 3 min at 94°C followed by 30-35 cycles of
denaturation at 94°C for 30 sec, annealing at 61°C for 30 sec and extension at 72°C
for 30 sec. A final extension step was performed at 72°C for 10 min. Amplification of
fragments that were subsequently used for sequencing or molecular cloning were
performed using Expand High Fidelity PCR System (Roche) according to the
manufacturer’s instructions.
Name Sequence (5’-3’) Location Æ
5’NXF1 TGCCAGAGCGGCCGCTGCTAGTAACAATAAGAGTGG 5’ of Vl1 s*
3’NFX1 GTT CTA GAG TGA CAA TAG TAA CGA 5’ of Vl1 as*
5’XF-3 TAA AAA GAA AAA AAA CAT AGG 5’ of Vl1 s
3’XF-2 CCA AGA TTG GGT TAA TGT ATC 5’ of Vl1 as
5’XbaI/XhoI CAG AAA TGC AAG CCC AGG AAG 3’ of Cl1 s
3’XbaI/XhoI TTA CTG GGG AAC ACA CTA CAC 3’ of Cl1 as
VJl1-int TTG TGA CTC AGG AAT CTG CA Vl1 exon s
VJl1-ext GGG TAT GCA ACA ATG CGC ATC TTG TC Vl1-LI* s
LAMINFOR GGA GCA GTC TGA AAT GAG ACA AAG CAT Jl1-Cl1 intron as
Cl1 CTC GGA TCC TTC AGA GGA AGG TGG AAA CA Cl1 exon as
5’Jl1#2 ACA GCC AAA ACT CAT CCA TAC CCA 5’ of Jl1 s
Msk GAT ATT GTG ATG ACC CAG TCT Vk exon s
CkE ACA CTC ATT CCT GTT GAA GCT CTT Ck exon as
m-b-actin-T CCT AAG GCC AAC CGT GAA AAG b-actin exon 2 s
m-b-actin-B TCT TCA TGG TGC TAG GAG CCA b-actin exon 4 as
Table I. Complete list of PCR primers. * abbreviations: LI, leader intron; s, sense strand; as,
antisense strand.
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Allele or cDNA Primer pair (s/as) Product [bp]
VJl1i VJl1-int/LAMINFOR 543
Igl GL 5’Jl1#2/LAMINFOR 1068
m-b-actin m-b-actin-T/m-b-actin-B 646
l1 light chain VJl1-int/Cl1 378
k light chain Msk/CkE ~600*
Table II. Genotyping and RT-PCR products. * Msk is a promiscuous primer and amplifies
most VJk-joints.
B 2.1.9 Southern blot analysis
5-15 mg DNA were digested o/n with 50 to 100 U of the appropriate restriction
enzyme. Subsequently, the DNA fragments were resolved by agarose gel
electrophoresis and transferred onto HybondTM-N+ (Amersham) or GeneScreenPlus
(Dupont) nylon membranes by an alkaline capillary transfer as described
(Chomczynski and Qasba, 1984). Membranes were baked at 80°C for 1 hour to
covalently link the DNA with the membrane. Membranes were then equilibrated in 2x
SSC (Sambrook et al., 1989) and prehybridized o/n in hybridization solution (1M
NaCl, 1% SDS, 10% dextran sulfate, 50 mM Tris-HCl pH 7.5, 250 mg/ml sonicated
salmonsperm DNA) at 65°C.
To generate Southern probes, 25 to 60 ng of probe DNA were radioactively labeled
with 2.5 mC a32P-dATP (Amersham) using the LaddermanTM Labeling Kit (Takara),
which is based on the principle of random primed oligolabeling [Feinberg, 1984
#215}. Unincorporated radiolabeled nucleotides were removed with MicroSpinTM S-
200HR columns (Pharmacia) to reduce background during hybridization. The probe
was denatured for 5 min at 95°C before it was added to the hybridization solution.
Hybridization was performed for at least 8 h at 65°C in a rotating cylinder (Hybaid).
After hybridization stringency washes were performed in the following order: 2x
SSC/0.1 % SDS, 1x SSC/0.1 % SDS and 0.2 x SSC/0.1 % SDS, if necessary. All
washes were done at 65°C under gentle agitation for 15 min to 1 hour. After each
wash the filter was monitored with a Geiger-counter. The washes were stopped when
specific signals of 20 to 100 cps were detectable. Then, the filter was sealed in a
plastic bag and exposed to X-ray film (Kodak XAR-5 or BioMAX MR; Eastman
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Kodak) at –70°C. Films were developed in an automatic developer (Agfa).
Alternatively, the filter was exposed at RT to a phosphoimager screen (Fuji) that was
analyzed on a Bio-Imaging Analyser (Fuji Bas 1000; Fuji).
The following probes were used for Southern blotting:
5’V1: This probe is located 5’ of the Vl1 gene outside the homology region and was
used as external probe to identify homologous recombination in ES cells. 5’V1 was
generated by PCR using primers 5'XF-3 and 3'XF-2 (see Table I), phage clone KX39
(covering 15 kb upstream of Vl1; gift from Ursula Storb) served as template.
3’C1: This probe is located downstream of the Cl1 exon in the long arm of homology
and was used to distinguish homologous recombination from random integration in
targeted ES cells. 3’C1 was generated by PCR using the primers 5'XbaI/XhoI and
3'XbaI/XhoI (see Table I), cosmid cos2 (gift from Ursula Storb (Miller et al., 1988))
was used as template.
RS-probe: This probe is located 5’ of the Igk RS element and was used to analyze RS
recombination. RS-probe was excised from plasmid pBM-RS (Durdik et al., 1984)
using BamHI and EcoRI.
5’Jk-probe: This probe is located 5’ of Jk 1 and was used to analyze Igk
rearrangement. 5’Jk1 was excised from plasmid pSP-Ig8 (Pelanda et al., 1996) using
EcoRI.
IL-4 probe: This probe hybridizes to the IL-4 gene and was used to normalize for
DNA content. IL-4 probe was excised from pIL-4T (Kuhn et al., 1991) using SmaI.
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B 2.2 Cell Biology
B 2.2.1 Embryonic stem cell culture
The VJl1i allele was generated through homologous recombination in Bruce-4 ES
cells (Kontgen et al., 1993). Culturing and transfection of ES cells was performed
according to published protocols (Pasparakis and Kollias, 1995; Torres and Kuhn,
1997). In brief, ES cells were cultured in ES cell medium (DMEM, 15 % FCS, 2 mM
sodium pyruvate, 2 mM L-glutamine, 1x non essential amino acids, 1:1000 LIF, 0.1
mM 2-b-mercaptoethanol) on a layer of mitotically inactive embryonic feeder (EF)
cells. LIF (Leukemia inhibitory factor, generated in our laboratory) was added to
ensure the maintenance of ES cell omnipotency in culture. Only FCS batches that
have been tested to promote ES cell growth and prevent premature in vitro
differentiation were used for ES cell culture. To obtain mitotically inactive EF cells,
fibroblasts from day 13 mouse embryos (prepared by Angela Egert) were passaged up
to three times in EF cell medium (DMEM, 10% FCS, 2 mM sodium pyruvate, 2 mM
L-glutamine) and subsequently treated with mitomycin-C (10 mg/ml for 2 h). ES and
EF cells were grown in tissue culture dishes (Falcon, Greiner) and kept at 37°C in a
humid atmosphere with 7.5% CO2. ES cells were passaged before colonies became
confluent. Colonies were washed once with PBS and then treated with trypsin (0.05 %
trypsin, 0.02 % EDTA in PBS; GIBCO-BRL) at 37°C until the cells detached from
the dish. Optimal conditions for trypsinization of Bruce-4 cells were achieved by
supplementing the solution with 1% chicken serum. This single cell suspension was
then used for passaging, transfecting or freezing. ES cells were frozen in FCS
containing 10 % DMSO at –80°C. Long time storage occurred in liquid nitrogen. For
transfection, 0.6 - 1 x 107 ES cells were mixed with 30 to 40 mg of DNA in 800 µl
PBS (GIBCO-BRL) and electroporated at RT (500 mF, 230V). Transfection time
constants ranged from 7 to 10 s. After transfection, ES cells were transferred onto an
embryonic feeder layer. From day 2, cells were kept in G418-containing ES cell
medium (150-200 mg/ml) to select for integration of the neoR gene. Selection against
HSV-tk containing random integrants started at day five after transfection by
supplementing the medium with 2 µM gancyclovir (Cymeven, Syntex). 8 to 12 days
after transfection, double resistant ES cell colonies were picked and split into EF-
containing 96-well tissue culture dishes for expansion.
Materials and Methods I 21
B 2.2.2 Preparation of cell suspensions from lymphoid organs
Spleens were strained through 70 µm nylon meshes (Becton Dickinson, Discovery
Labware) to obtain single cell suspensions. Bones were flushed with medium to
extract bone marrow cells and the peritoneal cavity was flushed with 10 ml of
medium to recover cells. Erythrocytes were lysed from spleen and bone marrow
preparations by incubation in lysis buffer for 3 min on ice (140 mM NH4Cl, 17 mM
Tris-HCl pH7.65). Cells were resuspended in medium (DMEM, 5% FCS, 2 mM L-
glutamine) and kept on ice prior to analysis.
B 2.2.3 Flow cytometry, cytoplasmic staining and cell sorting.
Single cell suspensions from bone marrow and spleen were stained with monoclonal
antibodies (mAbs) or polyclonal Abs conjugated to fluorescein isothyocyanate
(FITC), phycoerythrin (PE), PerCP or biotin. Biotin conjugates were visualized with
Streptavidin-allophycocyanin (APC). The IgG1-digoxigenin (DIG) conjugate was
detected by fluorescein-coupled anti-DIG Fab fragments (Roche). For additional
cytoplasmic stainings, cells were subsequently fixed in PBS/2% formaldehyde for 20
min at RT. Generally, 106 cells were stained in 50 µl staining buffer (PBS, 0.5% BSA,
0.05% N3). Intra-cellular staining was performed with FITC conjugated Ab in staining
buffer containing 0.05% saponin. Monoclonal antibodies, listed in Table 3, were
either prepared in our laboratory by C. Uthoff-Hachenberg and B. Hampel or
purchased from the indicated suppliers. Cells were acquired on FACSCalibur and data
were analyzed with CellQuest software, cell sorting was performed on FACS Vantage
with the help of C. Goettlinger and N. Barteneva. Instruments and software were from
Becton Dickinson (USA). All analyses were restricted to cells within the lymphocyte
gate. Dead cells were labelled with propidium iodide or Topro-3 prior to acquisition
and excluded from the analysis.
B 2.2.4 Magnetic cell sorting
Specific cell populations were either sorted or depleted from a heterogenous cell
suspension by magnetic cell sorting (MACS; Miltenyi Biotec). Cell populations were
labelled with antibody-coupled microbeads (50 µl beads, 450 µl staining buffer per
107 cells) and separated on LS MACS-columns in a magnetic field (Miltenyi et al.,
1990). The purity of isolated populations was subsequently tested by FACS analysis;
MACS-isolated lymphocytes were typically ≥ 90% pure.
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Specificity Clone     Reference and supplier (all USA)
IgM R33-24.12 lab-made (Gruetzman, 1981)
IgM (1B4B1) eBioscience
IgD 1.3-5 lab-made (Roes et al., 1995)
IgG1 X56 gift from Miltenyi
IgG2ab G12-47/30 lab-made (Seemann, 1981)
IgG2b R14-50 lab-made (Gruetzman, 1981)
IgE 95.3 lab-made (Baniyash and Eshhar, 1984)
Igk R33-18-10 lab-made (Gruetzman, 1981)
Igk 187.1 Pharmingen
Igl gam Igl Southern Biotech
Igl1 L22.18.2 gift from S. Weiss
NP B1-8µ lab-made (Reth, 1981)
NP S43-10 lab-made (Wildner, 1982)
NP S24/63/63 lab-made (Baumhackel et al., 1982)
NP N1G9 lab-made (Cumano and Rajewsky, 1985)
NP D3-13 F1 lab-made (Gause-Pfreundschuh, unpublished)
NP S8 lab-made (Reth, 1981)
NP 233.1.3 lab-made (Siekevitz et al., 1987)
B220/CD45R RA3-6B2 lab-made (Coffman, 1982)
CD3e 145-211 Pharmingen
CD5 53-7.3 Pharmingen
CD19 1D3 Pharmingen
CD21/CD35 7G6 Pharmingen
CD23 B3B4 Pharmingen
CD24/HSA M1/69 Pharmingen
CD25 (IL2Ra) PC61.5 eBioscience
CD43 S7 Pharmingen
HSA 30F1 lab-made (Ledbetter and Herzenberg, 1979)
Table III. List of antibodies used for flow cytometry.
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B 2.2.5 Cytospin and cytoplasmic staining on glass slides
Ex vivo isolated bone marrow cells were resuspended in PBS, 0.5% BSA, 0.05% N3 at
5 x 105 cells/ml. 105 cells were centrifuged onto a glass slide at 350 rpm for 4 min in a
Cytospin3 centrifuge (Shandon). The slides were subsequently dried at RT. To fix the
cell spots, slides were incubated in 95% EtOH/5% glacial acetic acid for 20 min at
–20°C. Slides were then washed once with PBS, twice with tap water and once with
PBS. For cytoplasmic staining, cell spots were incubated for 20 min at RT in a wet
chamber with 10-20 µl of fluorochrome-coupled or biotinylated antibody. Biotin
conjugates were visualized using streptavidin coupled to Alexa 350 (Molecular
Probes). Slides were washed after each staining step as described above. Before
adding the cover slip, 1 drop of Gel/Mount (Biomeda) was added onto the cell spot to
prevent fluorochrome fading. Slides were analyzed using an Axiovert 200M
fluorescent microscope (Zeiss) and Openlab software (Improvision).
Specificity Clone and conjugate Reference and supplier
IgM R33-24.12; biotin lab-made
Igk gam Igk; TRITC* Southern Biotech
Igl gam Igl; FITC Southern Biotech
Table IV. List of antibodies used for cytoplasmic stainings of glass slides. * Tetramethyl
rhodamine isothiocyanate.
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B 2.3 Mouse Experiments
B 2.3.1 Mice and general experimental procedures
C57BL/6 mice were obtained from Charles River. CB20 mice were generated and
maintained in our animal facility. All animals were kept under standard conditions in
conventional mouse facilities. Mouse experimental procedures and surgery essential
for the generation of VJl1i knock-in mice were performed by A. Leinhaas and A.
Egert. The general handling and marking of mice was done according to Hogan
(Hogan et al., 1987) and Silver (Silver, 1995).
B 2.3.2 Immunizations
Primary T dependent antigen responses were induced with alum-precipitated
phycoerythrin (PE) (Cyanotech Corporation). The immunogen was prepared by
mixing 1 volume of PE (0.1 mg/ml in PBS) with 1 volume of Imject Alum (Pierce).
To allow precipitation of PE in alum, the solution was incubated at RT for 30 min and
mice were subsequently immunized by intraperitoneal (i.p.) injection of 200 ml of the
precipitate.
B 2.3.3 Serum Analysis by ELISA
Ig serum concentrations were determined by C. Uthoff-Hachenberg and S. Willms via
enzyme-linked immunosorbent assays (ELISA, (Kendall et al., 1983)) as described in
Roes and Rajewsky (Roes and Rajewsky, 1993). Microtiter plates (Costar) were
coated in PBS plus reagent at 4°C o/n and subsequently blocked at RT for 30 min in
PBS, 0.5 % BSA, 0.05 % N3, pH 7.2. Next, serially diluted sera samples were added
to the wells and incubated at 37°C for 1 hour. Secondary biotinylated antibody was
added for 1 hour at 37°C. Detection of the biotinylated reagent was achieved with
SA-conjugated alkaline phosphatase (AP, Roche: 30 min at RT) and p-
nitrophenylphosphate as substrate (Roche). Following each incubation step, unbound
antibodies or SA-conjugated AP were removed by five washes with tap water. To
determine the respective Ig serum concentration, the absorption at 405 nm (OD405) of
each sample was measured with an ELISA-photometer (SpectraMax, Molecular
Devices) and compared to that of a standard of known concentration.
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Coating Biotin-Conjugate Specificity Standard
R33-24.12 gam IgM (SBA) IgM B1-8m
gam IgG1 (Sigma) gam IgG1 (SBA) IgG1 N1G9
G12-47/30 G12-47/30 IgG2ab S43-10
gam R14-50 IgG2b (SBA) IgG2b D3-13F1
gam 2E.6 IgG3 (SBA) IgG3 S24/63/63
gam IgA (Sigma) gam IgA (SBA) IgA 233.1.3
187.1 R33-18-10.1 k S8
L22.18.2 gam l (SBA) l N1G9
Table V. Antibody combinations to determine serum antibody isotypes. For references, see
Table III.
B 2.3.4 BrdU incorporation analysis
BrdU labeling and analysis was performed using BrdU Flow Kit (BD PharMingen)
according to the manufacturer’s instructions. In brief, mice were injected with 1 mg
BrdU i.p. and analyzed at the indicated time-points thereafter. Bone marrow single
cell suspensions were stained for B220, Igk and Igl1, fixed, DNase treated and
subsequently stained for BrdU incorporation.
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B 3 RESULTS
B 3.1 Expression of an inserted l1 light chain is developmentally
regulated and independent of Igk rearrangement
B 3.1.1 Targeted insertion of a pre-rearranged VJl1 gene segment into the Igl
locus
To generate Igl-transgenic mice in which the expression of the transgenic l light
chain is regulated by its physiological control elements, I inserted a pre-rearranged
VJl1 gene into the Igl locus via homologous recombination in murine embryonic
stem (ES) cells. A targeting vector was designed to replace 18 kb of genomic DNA
spanning from Vl1 to Jl1 by a pre-rearranged VJl1 gene (see Figure 2A and B).
This region contains the JCl3 cluster but no apparent cis-regulatory elements
according to DNase hypersensitivity assays in various cell lines (Hagman et al.,
1990). A 2.8 kb short arm of homology (SAH) located 5’ of Jl1 was generated in two
steps: in order to introduce a NotI site at the distal end of the SAH for linearization of
the final vector, phage clone KX39 (covering 15 kb upstream of Vl1, gift from
Ursula Storb) was PCR-amplified using the primer pair 5’NXF1 and 3’NXF-1 (see
Table I). The PCR product was cut with NotI and EcoRI to obtain the distal SAH
fragment. The proximal SAH fragment, which also contains the pre-rearranged VJl1
gene, was excised from pA8-6l (gift from Sigfried Weiss) with EcoRI and AccI. PCR
was used to introduce a silent GTCÆGTG (codon 36) mutation in framework region
2 of VJl1, which destroys an AvaII restriction site and thus allows the targeted allele
to be distinguished form an endogenous rearrangement. A 5.4 kb AccI/EcoRI
fragment located 3’ of Jl1 and excised from cosmid cos-2 (gift from Ursula Storb
(Miller et al., 1988)) served as long arm of homology (LAH). A loxP flanked ACN
cassette containing the cre-recombinase gene under the control of the sperm-specific
ACE promotor and the neoR gene driven by the ubiquitously expressed
Phosphoglycerate kinase promoter (PGK) (excised with EcoRI and XhoI from pACN
(Bunting et al., 1999)) was cloned into an intronic AccI site downstream of Jl1. The
ACN-cassette is deleted in chimeric mice during spermatogenesis. To select against
random integration, a thymidine kinase (TK) gene (excised with XhoI and SalI from
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pBS-TK (Thomas and Capecchi, 1986)) was inserted 3’ of the LAH. The targeting
construct was linearized with NotI and transfected into Bruce4 C57BL/6 embryonic
stem (ES) cells (Kontgen et al., 1993) as described in chapter 2.2.1. G418- and
gancyclovir- resistant ES cell clones were screened for homologous recombination by
Southern blot analysis using a BamHI digest and external probe 5’V1 (data not
shown). To exclude additional random integration of the targeting vector, correctly
targeted ES cell clones were digested with EcoRI and hybridized to internal probe
3’C1. Seven out of 480 double-resistant ES cell clones were homologous integrants.
Two of these were injected into CB20 blastocysts and the resulting chimeric males
were bred to C57BL/6 females for germline transmission. Figure 2 shows a schematic
of the targeting strategy and the verification of both a targeted ES cell clone and its
germline transmission with concomitant neoR deletion by Southern blotting. The
mutant Igl allele (referred to as VJl1i) mimics the WT Igl allele after Vl1ÆJl1 
rearrangement. The VJl1 gene was chosen since it is the predominant Igl
rearrangement in mice (Sanchez et al., 1996).
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Figure 2: Targeted insertion of a rearranged VJl1 gene segment into the germline of the
Igl locus. (a) Overview of the genomic organization of the Igl germline locus. The Igl 
locus is composed of three functional Jl-Cl clusters (JCl1-3) and one pseudo Jl-Cl cluster
(JCl4). Three Vl gene segments have been identified; Vl1, Vl2 and Vlx (Miller et al.,
1988; Storb et al., 1989). Constant region (C) exons are depicted as hatched boxes, V
segments as open boxes, J segments as closed boxes. Numbers indicate distances between
selected exons in kb (Gerdes and Wabl, 2002). (b) Partial restriction endonuclease map of the
Igl germline locus (Igl GL), the mutated allele after homologous recombination (VJl1i-
ACN) and the mutated allele after Cre-loxP mediated deletion of the neoR containing ACN
cassette (VJl1i). Arms of homology are shown in bold in VJl1i-ACN. V, J and C region
gene segments are indicated as described in (a), loxP sites are shown as open triangles.
Double headed arrows and associated numbers depict the indicative restriction fragments and
their respective sizes as revealed by either an external probe (5'V1) or an internal probe
(3'C1). B, BamHI; R, EcoRI. (c) Southern blot analysis of one injected ES cell clone (VJl1-
ACN), a heterozygous mouse mutant (VJl1i/+) and a wild-type littermate (+/+). ES cell or
thymic genomic DNA was digested with EcoRI and hybridized with 3'C1.
B 3.1.2 All mature B cells of VJl1i mice express the inserted l1 light chain
The inserted l1 light chain is expressed in all mature B cells of VJl1i mice (Figure 3)
and the distribution of peripheral B cell subsets appeared normal (data not shown). Ig
serum titers, except for IgA, were comparable to WT controls (Figure 4A), and the
majority of serum Ig is l1+ (Figure 4B) indicating that l1+ B cells contribute
normally to serum IgM and serum IgG. Since IgA is predominantly generated in gut-
associated lymphoid organs (reviewed in (Fagarasan and Honjo, 2003)), the increase
in IgA serum titers may reflect preferential activation of l1+ B cells in response to gut
derived pathogens. The total number of splenic B cells in VJl1i mice was reduced by
35% when compared to WT mice (2.3 x107±0.6x107 and 3.5x107±1.0x107 B cells,
respectively). A similar reduction in B cell numbers has been reported for mice that
carry an inserted VJk gene (Pelanda et al., 1996) and may reflect the restricted B cell
repertoire in mice that predominantly express one particular light chain. The majority
of splenic B cells in VJl1i mice express l1 exclusively. However, a substantial
fraction of B cells (~30%) express both l1 and k on the surface and less than 5%
appear to have lost surface expression of l1 (Figure 3A). Due to the organization of
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the Igl  locus, the VJl1 gene cannot be deleted by “secondary” VlÆJl
rearrangements (see Figure 2A). B cells that lack surface l1  expression may
represent naive B cells with inefficient heavy/l1 light chain pairing or memory B
cells that have inactivated the VJl1 coding region through somatic hypermutation
(see chapter 3.2.2). A semi-quantitative RT-PCR analysis of sorted l1+, k/l1+ and k+
splenic B cells from VJl1i mice confirmed that the inserted gene segment is
transcribed at similar levels in both surface l1-positive and -negative subpopulations
(Figure 3B).
Figure 3: All mature B cells of VJl1i/+ mice express the inserted l1 light chain gene. (a)
Representative staining for k and l1 on CD19+ splenocytes from VJl1i/+ and WT mice.
Numbers indicate the percentage of cells per quadrant. (b) Semi-quantitative RT-PCR
analysis of sorted k+, l1+ and k/l1+ splenic B cells from WT mice and VJl1i/+ mice. Testis
RNA from WT mice served as negative control. Serially diluted cDNA was analyzed for
reverse-transcribed l1- and k-LC message by PCR. A b-actin PCR was performed as internal
control.
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Figure 4. Serum Ig titers in VJl1i/+ mice. (a) Concentrations of indicated Ig isotypes from
adult VJl1i/+ mice (closed circles) and WT controls (open circles). (b) Concentrations of
total Igk and Igl1 in adult VJl1i/+ and WT mice.
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B 3.1.3 Expression of a pre-rearranged l1 light chain is developmentally
controlled like that of a pre-rearranged k light chain
I next assessed whether the pre-rearranged VJl1 gene is expressed in a
developmentally regulated fashion. In WT mice, IgL rearrangements occur mainly in
pre B cells and functional k light chains can be detected in ~20% of pre B cells
(Pelanda et al., 1996). However, it has been demonstrated that IgL rearrangements
can occur in a small fraction of pro B cells independently of IgH rearrangements
(Ehlich et al., 1993; Novobrantseva et al., 1999). To detect light chain expression in
WT and IgL insertion mice, I performed intracellular stainings for Igk or Igl light
chains in pro and pre B cells. The light chain expression pattern in WT mice is in
accordance with published results (Figure 4 and (Pelanda et al., 1996)) and shows
fourfold less k+ pro than pre B cells. VJl1i mice show a similar, developmentally
regulated expression pattern for the inserted light chain with three- to fourfold less l+
pro than pre B cells (Figure 5). This expression pattern is comparable to that of an
inserted k light chain in mice that carry a pre-rearranged VJk gene and either retain
(in the case of the D23ki allele (Novobrantseva, 2000)) or lack (in the case of the
LN1k allele (Hochedlinger and Jaenisch, 2002)) the genomic sequence between Vk
and Jk (Figure 5). The fractions of pro and pre B cells that express the inserted light
chain in either VJki or VJl1i mice are 4-5 fold increased when compared to k+ pro
and pre B cells in WT mice. Since only one third of newly formed rearrangements in
WT B cell progenitors is expected to be productive, the fractions of pro and pre B
cells that undergo IgL rearrangement in WT mice correspond approximately to the
fractions of pro and pre B cells that express the pre-rearranged light chain in IgL
insertion mice. I therefore conclude that transcription of inserted k and l1 light chain
genes is regulated similarly and coincides developmentally with the initiation of Igk
rearrangements in WT mice.
Results I 33
Figure 5: Intracellular light chain expression in CD25+ pro B cells and CD25- pre B cells
of light chain insertion and WT mice. Bone marrow lymphocytes were stained for surface
expression of B220, IgM and CD25 and for intracellular light chain expression. Flow
cyometric analyses of intracellular k and l expression in CD25-, B220+, IgM- pro B cells and
CD25+, B220+, IgM- pre B cells are shown for WT, VJl1i, D23ki and LN1k mice. Light
chain expression is plotted against cell size (Forward Scatter, FSC). Numbers indicate the
percentage of light chain expressing cells. Similar results were obtained in three or more
independent experiments.
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B 3.1.4 The majority of mature B cells in VJl1i mice carries the Igk locus in
germline configuration
It has been shown previously, that a pre-rearranged VJk gene efficiently drives pre B
cell to immature B cell differentiation without allowing Igk rearrangements to occur
(Pelanda et al., 1997). Simultaneous initiation of transcription of pre-rearranged VJk
and VJl1 genes suggests that the same phenomenon may occur in VJl1i mice. To
determine the extent of recombination at the Igk locus in B cells from VJl1i mice,
k/l1+ and l1+ B cells were sorted and analyzed for VkÆJk rearrangements and RS
recombination by Southern blotting. Thymocytes served as negative control. To
detect RS recombination, DNA was digested with EcoRI and hybridized to RS-probe
(Durdik et al., 1984) resulting in a 5.8 kb RS-germline fragment which is lost upon
RS recombination. To detect VkÆJk rearrangements, DNA was digested with
EcoICRI and hybridized to 5’Jk-probe (Pelanda et al., 1996) giving rise to a 4.5 kb k-
germline fragment. Depending on the orientation of the Vk  segment, Igk-
rearrangements lead to deletion or inversion of the DNA between Vk and Jk. In both
cases, the characteristic 4.5 kb fragment is lost. To control for DNA loading, blots
were stripped and rehybridized with an IL-4 gene specific probe (Kühn et al., 1991)
yielding a 10 kb fragment for the EcoRI digest and a 4.8 kb fragment for the EcoICRI
digest. Individual samples were assayed for the retention of a germline EcoIRCI
fragment spanning the Jk region and for the retention of a germline EcoRI fragment
spanning the RS region (Figure 6).
While the majority of l1+ B cells from WT mice were shown to carry two rearranged
Igk alleles (Coleclough et al., 1981; Takeda et al., 1993), more than 75% of l1+ B
cells from VJl1i mice retain the Igk locus in germline configuration (Figure 6B). RS
recombination is not detectable above background in VJl1i mice. In l1+ B cells of
WT mice, on the other hand, more than 60% of Igk alleles have undergone RS
recombination (Figure 6C), which is in accordance with published results (Coleclough
et al., 1981). Together, these data imply that in VJl1i mice, the majority of pre B cells
express the inserted l1 light chain gene and subsequently enter the immature B cell
compartment before endogenous Igk rearrangements have occurred.
Results I 35
Figure 6: Only low levels of Igk gene rearrangements occur in l1+ B cells of VJl1i/+
mice. (a) Partial restriction endonuclease map of the germline Igk locus (not to scale). V, J
and C gene segments, the 5'Jk probe and the RS-probe are shown as boxes, the asterisk
indicates a pseudo-J segment. The internal k enhancer (iEk) is shown as open circle, triangles
depict RS recombination sites. The arrows below the V gene segments indicate their
transcriptional orientation. The sizes of the germline EcoIRCI fragment and the germline
EcoRI fragment are indicated as revealed by probes 5'Jk and RS, respectively. E: EcoIRCI; R:
EcoRI. (b) and (c) Genomic DNA of sorted k+, k/l1+ and l1+, CD19+ B cells from VJl1i/+
and WT mice was analyzed by Southern blotting. To detect VkÆJk rearrangements, DNA
was digested with EcoIRCI and hybridized to 5'Jk probe (b). RS-rearrangements were
analyzed using an EcoRI digest and RS probe (c). Re-hybridization with an IL-4 gene-
specific probe served as internal control. The percentage of cells retaining either the
Igk  germline- or the RS germline-fragment is shown for each lane. Asterisks indicate
fragments that originate from VJ recombination by inversion.
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B 3.1.5 Co-expression of k and l1 light chains in VJl1i mice is likely to be the
consequence of receptor editing
The appearance of k/l1+ mature B cells in VJl1i mice indicates that a fraction of l1+
B cells has undergone Igk rearrangements and has thus escaped isotype exclusion.
Given the findings described above, this can only be explained by Igk rearrangements
occurring in a subpopulation of pro B cells (Ehlich et al., 1993; Novobrantseva et al.,
1999) or by secondary Igk rearrangements in a fraction of l1+ pre B cells. In VJki
mice, pre B cells that undergo secondary light chain rearrangements were shown to
take longer to exit the pre B cell compartment than pre B cells that express the pre-
rearranged light chain gene (Casellas et al., 2001). We thus compared the kinetics of
pre B to immature B cell transition for l1+ and k/l1+ B cells from VJl1i mice. WT
pre B cells were analyzed in parallel as a control for cells that undergo IgL
rearrangements. Large, cycling pre B cells were pulsed with BrdU in vivo and the
fraction of BrdU+ immature B cells was determined at different time-points thereafter.
Immature B cells were subdivided according to light chain expression (Figure 7A).
Figure 7B shows a comparison of BrdU-incorporation kinetics in WT and VJl1i
mice. Two conclusions can be drawn from this analysis. First, in VJl1i mice, k/l1+ B
cells exit the pre B cell compartment ~12h later than B cells that express only l1 and
thus appear to be the consequence of secondary Igk rearrangements. Second, WT B
cells exit the pre B cell compartment with kinetics similar to k/l1+ B cells from VJl1i
mice. The delay with respect to B cells that carry an inserted light chain is likely to
reflect the kinetics of Igk rearrangements in WT mice. The accelerated pre B cell to
immature B cell differentiation of cells expressing an inserted light chain has also
been observed in VJki mice (Casellas et al., 2001) and no major differences were
observed in the frequency of BrdU+ immature B cells of either VJki or Vl1i mice
(Figure 7C). This result further corroborates the conclusion that expression of pre-
rearranged k and l1 light chain genes is initiated simultaneously in pre B cells.
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Figure 7. BrdU incorporation in immature B cells. Mice were i.p. injected with BrdU and
analyzed at different timepoints thereafter. Immature B cells were defined as B220low/l1+ and
were subdivided according to Igk expression. (a) Representative histograms from a mouse
analyzed 30h after BrdU injection. The percentage of BrdU+ cells in k- (left) and k+ (right) B
cell subpopulations was determined as shown. (b) and (c). The percentage of BrdU+ immature
B cells is plotted against the time after BrdU injection. VJl1i/+ mice (circles) were compared
to either WT mice (squares) (b) or D23ki/+ mice (diamonds) (c). Open symbols correspond to
l1+ immature B cells, closed symbols depict k+ immature B cells in WT and D23ki/+ mice or
k/l1+ immature B cells in VJl1i/+ mice. Each pair of symbols represents one animal.
B 3.1.6 DNA methylation in the Jl1-Cl1 intron is developmentally regulated but
not required for Igl rearrangement
Despite the developmentally regulated expression of the inserted VJl1 gene, I cannot
rule out that accessibility for transcription and/or rearrangement differs between a pre-
rearranged and an unrearranged Igl locus. One way to address chromatin accessibility
of a particular genetic locus is the analysis of its DNA methylation pattern. It has been
previously shown that demethylation of the Jk region developmentally coincides with
VkÆJk rearrangement, and Igk rearrangements are confined to the demethylated
allele. Demethylation of the Jk region is acquired during the pre B cell stage and
appears to persist in mature B cells (Mostoslavsky et al., 1998). Here, I analyzed the
methylation status of the Jl1 region in the Igl locus in mature wild-type B cells using
three methylation-sensitive restriction enzymes: two of these recognize their DNA
target sequence only if it is unmethylated  (AvaI, AclI), whereas the third one requires
DNA methylation in order to cut (MrcBCI) (Figure 8A). DNA samples from sorted B
and T cells were digested with EcoRI in the presence or absence of the methylation-
sensitive enzyme and subsequently analyzed by Southern blotting using probe 3’C1
(see Figure 2). The EcoRI digest distinguishes the rearranged VJl1 allele from the
germline Igl  allele. The former yields a 7.5 kb fragment, the latter an 8.9 kb
fragment. AvaI, AclI and MrcBCI cut both the germline Jl1-Cl1 fragment and the
rearranged VJl1 fragment into sub-fragments that are indistinguishable when
hybridized to probe 3’C1. The resulting fragment sizes are shown in Figure 6A. More
than 50% of Igl alleles are demethylated in splenic B cells and considerably less or
no detectable demethylation is found in T cells, indicating that demethylation of the
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Jl1-Cl1 region is specific for B cells (Figure 8B, C). However, this process is not
necessarily linked to Igl rearrangement, since the majority of splenic B cells carry
germline Igl loci. Indeed, in sorted l1+ splenic B cells, AclI-demethylation can be
detected to similar extents (~50%) on both the unrearranged and the rearranged Igl
allele (Figure 8D). Therefore, AclI-demethylation is not required for Igl
rearrangement. To determine whether AclI-demethylation is developmentally
regulated, I analyzed sorted CD19+ pro B cells that were derived from the bone
marrow of RAG1-/- mice. RAG1-/- mice cannot rearrange their Ig loci and B cell
development is arrested at the pro B cell stage resulting in a considerable increase in
pro B cell numbers (Mombaerts et al., 1992). No AclI-demethylation could be
detected in RAG1-/- pro B cells (Figure 8E). Thus, the Jl1 region appears to be
demethylated in a developmentally regulated manner only after the pro B cell stage.
Taken together, these results imply that Jl1-Cl1 demethylation reflects a B cell
specific change in chromatin accessibility of this part of the Igl locus, which is,
however, not required for Igl rearrangement.
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Figure 8. Demethylation of Igl locus is B cell specific and developmentally
regulated. (a) Partial restriction endonuclease map of the Igl germline EcoRI
fragment spanning the Jl1-Cl1 region. Boxes depict exons and Southern probe 3’C1.
Acl, AclI; Ava, AvaI; M, MrcBCI. Fragment sizes as detected with probe 3’C1 are
indicated for each restriction site. (b) and (c) Southern blot analysis of B220+ and
B220- splenocytes from adult mice. Genomic DNA was digested with EcoRI (RI) +/-
methylation sensitive restriction enzymes MrcBCI (Mrc), AvaI (Ava) or AclI (Acl).
C, fragment corresponding to demethylated restriction sites; mC, fragments
corresponding to methylated restriction sites. (d) Southern blot analysis of sorted k+
and l1+ splenic B cells from adult mice. Genomic DNA was digested as indicated.
Fragments corresponding to the methylated germline Igl locus (IglGL mC), the
methylated Igl locus upon Vl1_Jl1 rearrangement (VJl mC) or the unmethylated Igl
locus (Igl/VJl  C) are indicated. In the latter case, the unrearranged and the
rearranged Igl alleles cannot be distinguished. (e) Southern blot analysis of sorted
CD19+ bone marrow B cells from a pool of 4 RAG1-/- mice. Genomic DNA was
digested as indicated, fragments are labeled as in (d). This result is representative of
two independent experiments.
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B 3.2 IgL double producers contribute normally to mature B cell
subsets and are counter-selected upon BCR-ligand interaction
B 3.2.1 Contribution of k/l1+ B cells to peripheral B cell subsets
In WT mice, allelic and isotype exclusion ensure the generation of monospecific B
cells and B cells that express two distinct light chains are therefore rarely found. Here,
we generated a system, where k/l1 double-producing immature B cells are readily
selected into the peripheral B cell pool and represent ~30% of mature B cells. To
determine the fate of k/l1+ B cells in VJl1i mice, we analyzed the distribution of
k/l1+ B cells in different B cell subsets. In the bone marrow, IgM+ cells can be
subdivided into immature B cells (B220low, IgM+) and mature, recirculating B cells
(B220high, IgM+) and the fraction of k/l1+ cells is slightly lower in the former (19%
and 24%, respectively). The fact that k/l1+ B cells represent ~35% of total B cells in
the spleen indicates positive selection of k/l1-expressing immature B cells (Figure
9A) into the peripheral B cell pool, but preferential homing of mature l1-single
positive B cells back to the bone marrow. While the former phenomenon may reflect
selection for a broader BCR repertoire, the reasons for the latter observation are
currently unknown.
In the spleen, CD19+ B cells were subdivided according to the expression of CD21
and CD23 into follicular (FO) B cells (CD21low, CD23+) and MZ B cells (CD21high,
CD23low). Both subsets harbor a similar fraction of k/l1+ B cells (~35%, Figure 9B).
In the peritoneum, the fraction of k/l1+ cells ranged from 20% to 40% between
individual mice but was comparable between B1 cells (CD19high, CD23-) and B2 cells
(CD19+, CD23+). Interestingly, l1 expression levels were greatly reduced in k/l1+
peritoneal B cells when compared to l1+ peritoneal B cells or splenic k/l1+ B cells
and this reduction could be observed in both B1 and B2 cells (Figure 9C). This result
suggests that expression of two distinct BCR specificities interferes with homing
and/or selection of B cells into the peritoneal cavity.
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Figure 9. Distribution of k/l1+ cells in peripheral B cell subsets. (a) IgL expression pattern
in immature (B220low/IgM+) and mature (B220high/IgM+) bone marrow B cells and CD19+
splenocytes from VJl1i/+ and WT mice. (b) CD19+ splenocytes from VJl1i/+ and WT mice
were subdivided into MZ and FO B cells according to CD21/CD23 expression as indicated.
Histograms show the fraction of k+ B cells in each subset. (c) Igl expression levels in k+
peritoneal B cells. B2 cells were identified as CD19low/CD23+, B1 cells as CD19high/CD23-.
Percentages indicate the fraction of cells that express Igl at levels comparable to CD19+, k+
splenocytes.
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B 3.2.2 Counter-selection of k/l1+ B cells in memory B cells
Given the selective pressure during affinity maturation of memory B cells, B cells
with dual receptor specificity are expected to have a selective disadvantage. To test
this hypothesis, VJl1i/+ mice were immunized with phycoerythrin (PE) in adjuvant.
PE is predominantly recognized by k+ B cells and therefore allows one to determine
the fate of k/l1+ B cells in a TD immune response. IgG1+ memory B cells were sorted
4 weeks after immunization according to their ability to bind PE. The majority of PE+
memory B cells did not or only weakly express l1 on the cell surface whereas PE-,
IgG1+ cells were predominantly l1+ (data not shown). Based on this result, I analyzed
the VJl1 gene for mutations that would inactivate l1 expression as a consequence of
somatic hypermutation. DNA from sorted cell populations was PCR amplified using
the primer pair VJl1-ext and LAMINFOR (see Table I) and subjected to sequencing.
While no deleterious mutations could be detected in PE-, IgG1+ B cells, 8 out of 18
mutated VJl1 sequences in PE+, IgG1+ B cells carried either frameshift mutations or
mutations that introduced pre-mature STOP codons (Table VI). This result suggests
that k/l1+ B cells that have inactivated one IgL allele through somatic hypermutation
during the germinal center reaction are preferentially selected into the memory
compartment.
genotype
mutated sequences/
total sequences
mutations/
mutated sequences
STOP
codons
Frameshift
PE-/l1+ 11/28 18bp/4370bp (0.4%) 0 0
PE+/l1- 18/31 81bp/7315bp (1.1%) 5 3 (1 STOP)
Table VI. Frequency of VJl1 gene inactivation in hypermutated IgG1+ B cells.
B 3.2.3 Reduction of k/l1+ B cells in class-switched bone marrow plasma cells
A subfraction of antigen-selected memory B cells terminally differentiates into long-
lived plasma cells and homes to the bone marrow. Counter-selection of k/l1+ memory
B cells should therefore extend to this specialized antibody-forming B cell subset.
IgM+ and IgM- bone marrow plasma cells from a VJl1i/+ mouse were analyzed for
their light chain expression pattern by immuno-histochemistry. While class-switched
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IgM- bone marrow plasma cells likely harbor a sizeable fraction of memory B cell
derived plasma cells, IgM+ plasma cells are thought to originate mainly from
extrafollicular immune responses. The latter can be activated in a polyclonal fashion
and are not necessarily antigen-selected. Consistent with this notion, the fraction of
k/l1+ IgM- plasma cells is reduced by approximately one third when compared to
mature splenic B cells, whereas only a slight reduction of k/l1+ cells is found in the
IgM+ subset (Figure 10). Interestingly, both IgM+ and IgM- subsets show a dramatic
increase in k+ plasma cells when compared to splenic mature B cells (30% and ~5%,
respectively). This may reflect inactivation of the VJl1i gene by somatic
hypermutation (see above) or inefficient IgH/Igl1 pairing. Taken together, these
results support the idea that B cells with dual receptor specificity are counter-selected
upon antigenic selection. However, single BCR specificity is not a requirement for
plasma cell generation since k/l1+ plasma cells are readily detected.
Figure 10. IgL expression in bone marrow plasma cells. Bone marrow plasma cells were
transferred onto glass slides by cytospin and subsequently stained for IgM, Igk and Igl. The
fraction of IgM+ and IgM- plasma cells that express either one or both IgL chain is shown.
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B 4 DISCUSSION
B 4.1 Transcription of an inserted VJl1 element is developmentally
controlled and independent of the VJk rearrangements
The predominance of Igk over Igl rearrangements in mice and humans has been
subject of extensive research over the last decades. There is suggestive evidence that
in B cell development, Igl may become accessible for V(D)J recombination later than
Igk  (Coleclough et al., 1981; Engel et al., 1999; Hieter et al., 1981). More
specifically, the analysis of targeted mutations in the Igk locus suggested the
existence of a negative regulatory signal that originates from an unrearranged Igk
locus and suppresses Igl gene rearrangements (Chen et al., 1993; Zou et al., 1993).
Based on evidence that Ig gene rearrangement correlates and is possibly
mechanistically connected with transcriptional accessibility of the target genes
(Casellas et al., 2002; Sun and Storb, 2001), I sought to test this hypothesis through
the analysis of the developmental expression pattern of a VJl1 rearrangement inserted
into its physiological position in the Igl locus. The results of this analysis were clear-
cut: expression of the inserted VJl1 element is developmentally controlled and
coincides with the developmental stage at which Vk and Jk gene segments are
rearranged and VJk-rearrangements are expressed (Figure 4); and VJl1 expression
does not depend upon Igk rearrangement (Figure 5). Thus, at the level of expression
of a gene rearrangement in the Igl  locus there is no evidence for sequential
accessibility of Igk and Igl and a signal originating from a non-rearranged Igk locus
that interferes with the transcription of a rearranged Igl locus can be excluded. This
in turn restricts a possible developmental program of successive accessibility of Igk
and Igl loci to the control of the initiation of IgL gene rearrangements. Such a
developmental program would further have to assume differential accessibility of
rearranged versus non-rearranged Igl loci during B cell development, which could be
due to juxtaposition of promoter and enhancer elements and/or the loss of cis-
regulatory elements upon Vl_Jl recombination. Although DNase-hypersensitive sites
have not been discovered in the intervening DNA (Hagman et al., 1990), cis-
regulatory elements could nevertheless exist in this region.
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I therefore analyzed chromatin accessibility of the unrearranged Igl locus in WT
mice. Chromatin accessibility and gene expression can be modulated by DNA
methylation, which has been shown to play an important role in the establishment and
maintenance of a silent chromatin state (Lee et al., 2001; Makar et al., 2003; Wilson
et al., 2002). Demethylation of DNA, on the other hand, is thought to create active
chromatin domains and Igk  rearrangement has indeed been correlated with
demethylation of the Jk region in mice (Mostoslavsky et al., 1998; Nakase et al.,
2003). Here, I show that parts of the Jl1-Cl1 region of the unrearranged Igl locus are
demethylated in a large fraction of mature B cells, but not in T cells, and that this
demethylation appears to be developmentally regulated (Figure 7). The fact that
demethylated Igl loci are not restricted to l+ B cells suggests that Igl loci are equally
accessible in k+ and l+ B cells. Whether the establishment of Igk- and Igl-
demethylation coincides developmentally is, at this point, subject to speculation.
Unlike in the Igk locus, no correlation between rearrangement and recombination
could be detected. This implies that demethylation of the Jl1-Cl1 region is not
functionally required for Igl rearrangement but may (indirectly) reflect chromatin
accessibility. Due to the limited number of methylation-sensitive restriction sites, this
analysis does, however, not cover the complete Jl1-Cl1 region and a correlation
between demethylation and Igl rearrangement at other Jl1-proximal sites is still
possible. Taken together, my results are in good agreement with models ascribing the
predominance of Igk over Igl rearrangements to a competition between the two loci,
in which the Igk locus is at an advantage.
Inefficient Igl rearrangements could be due to differences in the quality of Igk- and
Igl-specific RSSs with respect to their affinity for the RAG1/2 complex. Indeed, it
has been demonstrated earlier that a pair of representative Igk RSSs rearranges more
efficiently than a pair of Vl1 and Jl1 RSSs in vitro (Ramsden and Wu, 1991).
Moreover, RSSs appear to be an important factor in determining the order of V(D)J
recombination in T cell receptor b locus (Bassing et al., 2000; Wu et al., 2003). Taken
together, these results strongly suggest that different RSSs have different
recombination properties. A targeted replacement of Igl-specific RSSs with Igk-
specific RSSs would address the impact of RSS recognition on Igl rearrangement.
Alternatively, competition for trans-activating factors might be responsible for
different rates of germline transcription at Igk and Igl. Interestingly, the rate of
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germline transcription has recently been shown to directly influence rearrangement in
both the Igk locus (Casellas et al., 2002) and the Igl locus (Sun and Storb, 2001). To
address potential differences in the efficiency of Igl and Igk germline transcription, it
will be interesting to analyze how Igk-specific enhancer elements might influence Igl
germline transcription and rearrangement when inserted into the Igl locus.
B 4.2 Receptor editing in VJl1i mice
While most pre B cells in VJl1i mice exert efficient isotype exclusion and do not
undergo Igk rearrangements, ~20% of immature B cells and more than 30% of mature
B cells express both a l1 and a k light chain on the surface (Figure 8). In VJki mice,
it has been shown that, depending on the inserted light chain, between 20% and 30%
of B cells change their antigen receptor by editing, thereby generating B cells that
express an endogenous VJk gene (Casellas et al., 2001). This process is thought to be
a means of revising the specificity of an otherwise self-reactive antigen receptor. The
fact that I readily detect small pre B cells that express a k LC in VJl1i mice (Figure
4) is consistent with the idea of secondary rearrangements in a fraction of l1+ pre B
cells. I further demonstrate that k/l1+ pre B cells take ~12h longer to exit the pre B
cell compartment than their l1+ counterparts (Figure 8B). A similar observation has
been reported previously to be the consequence of receptor editing in pre B cells
(Casellas et al., 2001). Two recent reports have proposed the generation of B cells
with dual receptor specificity as a means to “dilute out” the signal strength of a single,
self-reactive B cell receptor, thereby circumventing anergy or clonal deletion (Kenny
et al., 2000; Li et al., 2002). This suggests that 20-30% of l1+ B cells in VJl1i mice
have undergone receptor editing in order to reduce the surface density of a self-
reactive IgH/Igl1 pair. This fraction is comparable to the fraction of editing k+ B cells
in WT mice (Casellas et al., 2001). It can be extrapolated from this result that a
maximum of two thirds of the IgH repertoire generated in WT mice can be expressed
in combination with l1 light chains.
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B 4.3 B cells with dual receptor specificity are counter-selected upon
BCR engagement
B cells with dual receptor specificity are a potential threat to the organism since
unspecific ‘bystander’ Ig molecules can be generated in the process of an otherwise
antigen-specific immune response and this may ultimately lead to autoimmunity (Li et
al., 2002). The low number (~1-2%) of IgL double producers in normal mice
(Casellas et al., 2001; Gollahon et al., 1988) suggests that such cells are either
inefficiently generated or efficiently counter-selected during B cell development.
Inefficient Igl rearrangement and concomitant inactivation of the Igk locus through
RS recombination supports the former scenario. Moreover, mice that carry two
prearranged IgH genes (Sonoda et al., 1997) as well as VJl1i/+ mice readily generate
mature B cells with dual receptor-specificity, indicating that these cells are not
counter-selected during the transition form immature to mature B cells. This
phenomenon raises the following question: are VJl1i mice able to prevent the
generation of unspecific and thus potentially harmful ‘bystander’ Ig responses? To
address this issue, I studied the fate of B cells with dual receptor specificity upon
antigen encounter or differentiation into specialized (Ig-producing) B cell subsets.
While k/l1+ B cells contribute equally to marginal zone and follicular B cell subsets
in the spleen, the results presented in this thesis suggest that B cells with dual receptor
specificity are counter-selected in the peritoneal cavity and in memory B cells; both B
cell subsets are known to depend on BCR-ligand interactions.
B 4.3.1 Selection of peritoneal B cells depends on BCR-ligand interaction
The majority of peritoneal B cells assume a B1 phenotype and are responsible for the
secretion of natural Igs. Based on results from BCR-transgenic mice, it has been
proposed that B1 cells are preferentially generated from B cells that harbor a modestly
autoreactive BCR and B1 cells thus appear to be BCR-ligand selected (Hayakawa et
al., 1999; Hayakawa et al., 2003). The fact that k/l1+ peritoneal B cells in VJl1i mice
have normal levels of k surface expression but 10-fold reduced l1 surface levels is
consistent with this idea (Figure 9C). Interestingly, peritoneal B1 cells and peritoneal
B2 cells appear to be equally selected, suggesting that BCR-ligand interaction is
important for homing and/or selection of B cells into the peritoneal cavity rather than
for the generation of B1 cells itself. In particular, signal strength and surface density
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of the BCR appear to be crucial factors in this process, putting B cells with two
distinct BCR specificities at a competitive disadvantage. A similar observation was
made when BCR-transgenic mice that predominantly produce B1 cells were crossed
with a second, B2 cell producing BCR-transgenic mouse strain: the majority of
double transgenic B cells in the spleen expressed both IgH chains and assumed a B2
phenotype, whereas peritoneal B cells had inactivated the second IgH allele through
somatic recombination (Lam and Rajewsky, 1999). Since the VJl1 gene cannot be
inactivated on the genomic level, strongly reduced l1 surface expression in k/l1+
cells is likely the consequence of inefficient pairing of IgH and Igl1. This in turn
means that the secretion of unselected, potentially harmful Igs through k+/l1low B1
cells cannot be excluded in VJl1i mice.
Given the functional similarities between B1 cells and MZ B cells as a first line of
immune defense to polyreactive antigens, it has been speculated that MZ B cells may
also be subject to BCR-mediated selection (Martin and Kearney, 2000b; Martin et al.,
2001). My results demonstrate that B cells with equal levels of two distinct BCR
specificities can readily form MZ B cells (Figure 9B). This result is consistent with
the idea that the generation of MZ B cells and peritoneal B cells may require different
levels of BCR-signaling and/or -surface density (reviewed in (Niiro and Clark,
2002)), yet, it does not allow conclusions with respect to antigenic selection. In
contrast to the results presented here, it has been reported previously that receptor-
edited B cells with dual receptor specificity accumulate in the MZ (Li et al., 2002).
However, in this particular case, B cells were transgenic for both IgH and IgL chains
and the observed accumulation may not be representative for a broad repertoire of
BCR specificities as it is found in k/l1+ B cells from VJl1i mice.
B 4.3.2 Inactivation of the VJl1 gene in memory B cells via somatic
hypermutation
While the necessity of BCR-ligand interaction during the selection of peritoneal B
cells is a relatively new concept, its importance in the generation of memory B cells is
well established and B cells with dual receptor specificity are expected to have a
selective disadvantage in the highly competitive germinal center environment. This
selective disadvantage was observed for the first time in mice that carry multiple
insertions of the same pre-rearranged Igk light chain. Mutations that improve the
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antibody affinity of one transgene copy cause antigenic selection to favor cells that
downregulate the other copies at multiple levels of gene expression. This includes
examples where nonsense mutations correlate with a drop in messenger RNA levels
(Lozano et al., 1993). Consistent with this prediction, I find that when VJl1i mice are
immunized with an antigen that is preferentially recognized by k+ B cells, 45% of
antigen-specific memory B cells have inactivated the VJl1 gene through somatic
hypermutation (Table VI) and have consequently lost l1 surface expression.
Moreover, unimmunized VJl1i mice show modest counter-selection of k/l1+ double
producers in class-switched bone marrow plasma cells, which are likely derived from
memory B cells. Taken together, these results suggest that B cells with dual receptor
specificity are generally counter-selected during TD immune responses. However, a
considerable fraction of bone marrow plasma cells express both IgL chains and it is
unclear whether or not these cells have been exposed to stringent antigenic selection.
Given that every k+ B cell that is recruited into germinal centers carries an intact
VJl1 allele and that individual germinal centers show varying degrees of affinity
selection (Kuppers et al., 1993; Vora et al., 1999), it is conceivable that some
germinal centers do not accumulate B cells with inactivated VJl1 genes. In addition,
certain TI antigens can lead to polyclonal B cell activation and class-switch
recombination resulting in both IgM+ and IgM- k/l1+ plasma cells (Litinskiy et al.,
2002). These cells have not been exposed to the highly selective environment of a
germinal center and enrichment for B cells that have inactivated one of the two light
chains is unlikely. However, further analyses are required to settle this issue.
Irrespective of their origin, it will be interesting to analyze whether the abundance of
k/l1+ plasma cells in VJl1i mice can lead to the generation of unspecific ‘bystander’
Ig molecules, which may eventually cause autoimmune disease. The fact that B cells
with two distinct receptors can be found in mice (Casellas et al., 2001; Gollahon et al.,
1988) and possibly humans (Hieter et al., 1981) raises the possibility that these cells
may promote the generation of B cell-mediated autoimmunity. In T cells,
coexpression of two different T cell receptors can lead to escape from self-tolerance
induction and T cells with dual receptor specificity were shown to cause organ-
specific autoimmune disease (Sarukhan et al., 1998).
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B 5 SUMMARY
The B cell antigen receptor (BCR) consists of two immunoglobulin heavy (IgH)
chains, two immunoglobulin light (IgL) chains and the signaling molecules Iga and
Igb. The variable regions of IgH and IgL chains confer antigen specificity and are
assembled from various gene segments through a unique series of somatic
recombination events. Ig rearrangement is a developmentally regulated process with
IgH rearranging prior to IgL. IgL rearrangements can take place on two distinct
genomic loci, Igl and Igk, but occur more frequently at the latter. Previous results
suggested that the unrearranged Igk locus negatively regulates Igl transcription
and/or rearrangement. Here, I demonstrate that expression of a pre-rearranged l1 light
chain gene inserted into the Igl  locus is independent of Igk  rearrangements.
Expression of the inserted l1 gene is developmentally regulated like that of a pre-
rearranged Igk gene inserted into the Igk locus and coincides developmentally with
the occurrence of Igk rearrangements in wild-type mice. I thus conclude that
transcription of a gene rearrangement in the Igl locus is developmentally controlled
and not negatively regulated by the unrearranged Igk locus.
Mice carrying an inserted l1 light chain gene undergo secondary IgL rearrangements
at a frequency that is comparable to WT mice. This process is presumably a
consequence of receptor editing in B cells that expressed an auto-reactive IgH/Igl1
pair. Unlike Igk rearrangements, Igl rearrangements cannot be deleted from the
genome and the resulting ‘receptor-edited’ l1+ B cells express both the inserted l1
light chain and an endogenous Igk molecule on the cell surface. While allelic and
isotype exclusion generally ensure that B cells express a unique receptor specificity,
my results indicate that dual receptor specificity poses no problem for the generation
of mature B cells. However, B cells with two distinct receptor specificities are
counterselected upon BCR-ligand interaction, which is a crucial event during immune
responses and possibly in the generation of B1 cells. Counterselection of Igk/Igl
double positive B cells can occur on the protein level and on the genomic level and
ensures the generation of an antigen-specific immune response.
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B 6 ZUSAMMENFASSUNG
Der B-Zellrezeptor besteht aus zwei schweren und zwei leichten Immunglobulin-
Ketten (IgH und IgL) und den für die Signalvermittlung verantwortlichen Molekülen
Iga und Igb. Die variablen Domänen der schweren und leichten Ketten sind für die
Antigen-Erkennung verantwortlich und setzen sich aus mehreren Gensegmenten
zusammen, die durch somatische Genumlagerungen in zeitlich regulierter Abfolge
zusammengesetzt werden. Genumlagerungen der IgH loci finden vor denen der IgL
loci statt. IgL-Umlagerungen können auf zwei unterschiedlichen Genloci initiiert
werden (Igl und Igk), wobei Igk bevorzugt wird. Es gibt Hinweise in der Literatur,
dass der nicht umgelagerte Igk Locus ein negatives Signal übermittelt, welches Igl
Genumlagerungen verhindert. In der vorliegenden Arbeit zeige ich, dass eine bereits
umgelagerte Igl1-Kette, die durch homologe Rekombination in den Igl Genlocus
integriert wurde, unabhängig von Igk-Genumlagerungen ausgeprägt wird. Die
Ausprägung dieser leichten Kette ist ähnlich reguliert wie die einer bereits
umgelagerten Igk-Kette, die in den Igk Genlocus integriert wurde, und findet zur
selben Zeit statt wie Igk-Genumlagerungen in WT Mäusen. Daraus folgt, dass die
Aussprägung einer Genumlagerung im Igl Locus zwar vom Entwicklungsstadium der
B-Zelle abhängig ist, aber nicht von Igk-Genumlagerungen beeinflusst wird.
Ähnlich wie in WT Mäusen findet man auch in Mäusen mit umgelagerter Igl1-Kette
20-30% sekundäre IgL-Genumlagerungen. Die Ursache dafür ist vermutlich eine
selbstreaktive IgH/Igl1 Kombination. Da Igl-Genumlagerungen im Gegensatz zu
Igk-Genumlagerungen nicht deletiert werden können, prägen l1+ B-Zellen mit
sekundären IgL Genumlagerungen zwei unterschiedliche B-Zellrezeptoren aus. In
WT Mäusen garantieren allele sowie isotypische Ausschliessung, dass B-Zellen
normalerweise nur einen einzigen B-Zellrezeptor ausprägen. Hier zeige ich, dass B-
Zellen mit zwei unterschiedlichen B-Zellrezeptoren problemlos reifen und in
sekundäre Lymphorgane gelangen können. Allerdings findet eine Gegenselektion
dieser Zellen statt, sobald der B-Zellrezeptor mit Antigen interagiert. Diese
Interkation spielt eine wichtige Rolle bei Immunreaktionen und wahrscheinlich auch
bei der Entstehung von B1-Zellen. Gegenselektion von Igk/Igl1 Doppelproduzenten
wurde sowohl auf der Ebene der Genausprägung als auch durch Geninaktivierung
erreicht und stellt eine ausschliesslich antigenspezifische Immunantwort sicher.
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C Part II) Novel approaches for Cre-mediated
inducible gene alteration in mice
C 1 INTRODUCTION
C 1.1 Manipulating gene expression in mice
The study of gene function in mice encompasses two complementary approaches:
gain of function and loss of function analyses. Gain of function is generally achieved
through overexpression of a certain gene product and thus directly addresses its
functional properties. Loss of function, on the other hand, represents an indirect
assessment of gene function as it involves gene inactivation. Since the severity of a
loss of function phenotype often reflects the importance of the respective gene, loss of
function studies are widely applied in mouse genetics. A classical way to generate
loss of function mutants is the inactivation of genes through targeted disruption or
‘knock-out’ of the gene of interest by homologous recombination in embryonic stem
(ES) cells (reviewed in (Capecchi, 1989)). An alternative way to achieve loss of
function mutants employs the recently discovered cell-intrinsic RNA interference
(RNAi) pathway (see chapter 1.2). This approach acts post-transcriptionally through
sequence-specific degradation or ‘knock-down’ of messenger RNA. While classical
gene inactivation generally requires targeted disruption of two alleles, RNAi-
mediated loss of function can be achieved using a single transgene. Moreover, RNAi
allows the simultaneous knock-down of several members of a highly homologous
gene family. A limitation of RNAi as a means to study loss of function phenotypes is
incomplete suppression of target mRNA. RNAi and gene targeting must therefore be
considered complementary approaches to study gene function in vivo.
C 1.2 RNA interference
RNAi is a highly coordinated mechanism involved in post-transcriptional gene
regulation and was first observed in the nemoatode worm Caenorhabditis elegans as a
response to double-stranded (ds) RNA (Fire et al., 1998). dsRNAs generally originate
from replicating RNA viruses or transposable and retroviral elements in the genome
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and RNAi is thought to have evolved as an innate antiviral host defense mechanism
(reviewed in (Hannon, 2002; Zamore, 2002)). During the initial steps of RNAi, the
ribonuclease (RNase) III-like enzyme Dicer processes long dsRNAs and complex
hairpin RNAs into small interfering RNAs (siRNAs) (Bernstein et al., 2001; Ketting
et al., 2001; Knight and Bass, 2001). siRNAs are generally 21 to 23 bp RNA duplexes
with characteristic dinucleotide overhangs (Zamore et al., 2000). These duplexes were
shown to be unwound in a reaction which is likely catalyzed by an RNA helicase
(Schwarz et al., 2003). Single-stranded (ss) siRNAs can then be incorporated into the
so-called RNA-induced silencing complex (RISC), which functions as an siRNA-
induced endonuclease. RISC cleaves target RNA with perfect complementarity to the
siRNA and thereby amplifies target RNA degradation (Hammond et al., 2000;
Nykanen et al., 2001). The sequence specificity of this process is illustrated by the
fact that even single point mutations in either the target RNA or the siRNA itself can
completely abolish silencing (Elbashir et al, 2001a).
Recent reports show the successful application of RNA interference (RNAi) as a tool
for post-transcriptional gene silencing in mammalian cells both in vitro and in vivo
(reviewed in Dykxhoorn et al., 2003). Induction of transient RNAi was accomplished
by direct application of siRNA duplexes (Elbashir et al., 2001; Song et al., 2003) or
by transfection with siRNA expression vectors (reviewed in (Tuschl, 2002)). These
vectors employ RNA polymerase III (polIII) to transcribe short hairpin RNAs
(shRNAs) (Brummelkamp et al., 2002; Sui et al., 2002), which are subsequently
processed into siRNAs by Dicer (Paddison et al., 2002). RNA polymerase III is
normally dedicated to the transcription of genes that encode structural or catalytic
RNAs such as tRNAs and components of the splicing machinery. The elongation
properties of RNA polIII are unique in that it recognizes a run of 4-5 T residues as a
termination signal. This allows the generation of short RNA molecules and RNA
polIII transcripts are generally no longer than 400 bp. RNA polIII promoters are
divided into three main types, two of which are gene-internal and commonly TATA-
less, one is gene-external and contains a TATA box. In the latter case, transcription is
initiated at a defined distance from the TATA box (25-32 bp) and thereby ensures the
precise generation of RNA polIII transcripts (reviewed in (Schramm and Hernandez,
2002)). These properties make TATA-containing RNA polIII promoters an ideal
choice to promote shRNAs transcription. To date, two RNA polIII promoters have
been successfully used to transcribe shRNAs, which then efficiently mediated RNAi.
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One of these promoters is derived from the human H1 gene (Brummelkamp et al.,
2002), the other from the human or mouse U6 genes (Paul et al., 2002; Sui et al.,
2002). In cell culture and in mice, stable expression of shRNAs was achieved using
shRNA expression cassettes that were integrated into the genome by either retroviral
or lentiviral gene transfer (Novina et al., 2002; Rubinson et al., 2003; Tiscornia et al.,
2003). However, lentiviral integration into the mouse genome occurs randomly and
hence yields unpredictable shRNA expression patterns. Targeted integration of an
shRNA expression cassette into a well-defined genetic locus will help to solve this
problem.
C 1.3 Conditional gene targeting – the Cre/loxP system
A major disadvantage of loss of function analyses is early lethality of the mouse
mutant if the target gene is crucial for embryogenesis. In the case of targeted gene
disruption, this limitation can be overcome by systems that allow cell-type specific or
developmentally regulated inactivation of genes in vivo. Such conditional gene
inactivation generally relies on prokaryotic recombinases that recognize specific DNA
target sequences and excise or invert the intervening DNA, which contains the gene
(segment) of interest. Recombinase expression can be regulated and genetic
manipulation can thereby be limited to the cell type or developmental time point of
choice. The most commonly used recombinase sytem is the Cre/loxP system
(reviewed in (Rajewsky et al., 1996; Tronche et al., 2002)).
Cre is a bacteriophage P1 derived 38 kDa protein that recognizes a 34 bp DNA target
termed loxP (locus of X-over of P1), which consists of two 13 bp inverted repeats that
serve as Cre-monomer binding sites and an 8 bp spacer region. The spacer region is
non-palindromic and provides the loxP site with an orientation; recombination can
occur between two loxP sites of either identical or opposing orientation. The former
results in excision of the intervening DNA, the latter in its inversion. Excision is
accompanied by the deletion of one loxP site from the genome and is therefore
essentially unidirectional. Inversion, on the other hand, yields two loxP sites that are
indistinguishable from the original loxP pair due to the conservative nature of the
recombination event (Guo et al., 1997), and recombination continues as long as Cre is
present. While the full reversibility of Cre-mediated gene inversion limits its
applicability as a genetic tool, Cre-mediated deletion is widely used to manipulate the
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mouse genome. As mentioned above, it allows cell-type specific and/or
developmentally regulated gene inactivation. In addition, deletion of loxP-flanked
transcriptional STOP cassettes can be applied to induce gene expression in a Cre-
dependent manner. Transcriptional STOP cassettes are located downstream of the
promoter of the gene of interest and contain several transcriptional and/or
translational termination elements (Lakso et al., 1992). Current technology limits this
approach to the induction of polII-mediated transcription and hence does not allow
Cre-mediated control of RNAi.
C 1.4 Site directed mutagenesis of loxP sites
Site-directed mutagenesis of loxP sites has led to the generation of mutant loxP pairs
that extend the applicability of Cre/loxP mediated gene alteration. Mutational
analyses involved both the spacer region and the inverted repeats. Mutations in the
spacer region were shown to interfere with recombination between non-identical
mutant loxP sites (Hoess et al., 1986). In the case of mutants lox5171 and lox2171,
recombination was demonstrated to occur exclusively within identical pairs (Lee and
Saito, 1998). This allows the use of two or more distinct, mutant loxP pairs at the
same time without the potential problem of cross-recombination between different
loxP-flanked alleles. Mutations in the inverted repeats are thought to interfere with
Cre-monomer recruitment and were shown to impair recombination efficiency
depending on the extent and site of the mutation (Albert et al., 1995). loxP sites in
which both inverted repeats are mutated display strongly reduced recombination
efficiency even in combination with WT loxP sites. These findings have been utilized
to generate loxP pairs that display a favorable forward reaction equilibrium. One such
loxP pair consists of two asymmetric, mutant loxP sites that carry a 5 bp-mutation in
the distal end of either the left (lox71) or the right (lox66) inverted repeat. Cre-
mediated recombination of lox66/lox71 yields one loxP site with two mutated inverted
repeats (termed lox72) and one WT loxP site (Figure 1). While lox66 and lox71
mediate recombination with an efficiency comparable to WT loxP sites in vivo in
plants, recombination efficiency between lox72 and WT loxP was up to 8 fold
reduced (Albert et al., 1995). More recently, two reports showed the successful
application of lox66/lox71-mediated recombination in mouse embryonic stem (ES)
cells (Araki et al., 1997; Zhang and Lutz, 2002). Although inversion appeared
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irreversible in ES cell colonies (Zhang and Lutz, 2002), a characterization of
lox66/lox71-mediated recombination in cre-transgenic mouse strains in vivo is still
missing.
Figure 1. Schematic representing the Cre-mediated recombination of lox66 and lox71
resulting in lox72 and loxP. Inverted repeats are shown in grey, black boxes symbolize 5 bp
mutations, the open box depicts the spacer region and the triangle represents its orientation.
The difference in arrow sizes reflects the unbalanced equilibrium between forward and
reverse reaction.
C 1.5 Objectives of this study
The broad applicability of the Cre/loxP recombination system and the existing variety
of mice that express Cre under inducible and cell-type specific promoters make this
system an ideal choice for conditional mutagenesis. The aims of my thesis were to
establish irreversible Cre-mediated genetic inversion in vivo and to combine Cre/loxP
technology with RNAi to allow for inducible knock-down of one or multiple,
homologous genes in mice. Both methods are expected to provide useful additions to
the toolbox of gene manipulation.
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C 2 MATERIALS AND METHODS
Only methods different from those described in part I are listed.
C 2.1 Molecular Biology
C 2.1.1 Purification of RNA and reverse transcription
Total RNA was isolated from 105-107 cells or approximately 100 mg of tissue using
TRIzol (Invitrogen) following the manufacturer’s protocol. All RNA work was done
using DEPC-treated H2O. cDNA was synthesized from 10
5-106 cells using oligo-dT
primer and Thermoscript RT-PCR System (Invitrogen) according to the
manufacturer’s instructions. 1/10 of the cDNA template was subjected to PCR (see
chapter 2.1.8).
C 2.1.2 Primers for polymerase chain reaction (PCR)
Name Sequence (5’-3’) Location Æ
LAH53 GGACCTCCATCTGCTCTTATTT 5’ of DQ52 s*
CDR3-PE GGTCTATTACTGTGCAAGTTGG CDR3 of VPE as
U6termRI TGTGAATTCGTTCCTCAGAGGAACTGA 3’ of U6 gene s
U6term1-B TGTGGATCCCCCGGGCGTGGCTTGGTGGTACACCTC 3’ of U6 gene as
XbaI-U6 GACTCTAGATCCGACGCCGCCATCTCTAG U6 promoter s
U6loxT-RI
TGCGAATTCAAAAATCGCAAAAACGTAATAACTTCGTATA
AGTATGCTATACGAAGTTATAGTCTCAAAACACACAATTA
CTTAC
U6 promoter as
A1d-X TGCTCGAGATGTCTGAGTACGAGTTCATGCATATC A1d cDNA s
mutA1-B CTGGATCCTTATTTCAGCAGGAACAGCATCTCCCATATCTG A1d cDNA as
A1d-B CTGGATCCTTACTTGAGGAGAAAGAGCATTTC A1d cDNA as
HPRT-SAH TTCCTAATAACCCAGCCTTTG pMP-10 SAH s
hHPRT-pro GTGATGGCAGGAGATTTGTAA hHPRT promoter as
Table I. Complete list of PCR primers. * abbreviations: s, sense strand; as, antisense strand
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C 2.1.3 Real time PCR analysis
Genomic DNA was subjected to quantitative PCR analysis using SYBR Green PCR
core reagents (Applied Biosystems) as described by the manufacturer and the iCycler
iQ Real-Time PCR Detection System (Bio-Rad). SYBR Green is an intercalating dye,
which binds all double-stranded DNA, regardless of the sequence, and will emit a
fluorescent signal. The SYBR Green dye binds amplified products during the
annealing and extension steps of each PCR cycle. The accumulation of amplified
DNA is measured by the increase in fluorescence over time and the specificity of the
amplification product can be evaluated by combining PCR with melt curve analysis.
Two serial 1:5 dilutions were included for each sample and served to determine mean
and standard deviation.
C 2.1.4 Southern blot probes and quantification
RH probe: RH probe is located downstream of the Eµ enhancer and was used as an
external probe to identify homolgous integration of the VNP-VPEinv targeting
construct. RH probe was excised from plasmid pRH (Sonoda et al., 1997) using
EcoRI and HindIII.
probe B: probe B is located upstream of the DH element DQ52 in the IgH locus and
served as an internal probe to verify homologous recombination and identify random
integration of the VNP-VPEinv targeting vector. Moreover, probe B was used to
analyze Cre-mediated inversion of the VNP-VPEinv switch cassette. Probe B was
excised from plasmid pDSP-Qi (Taki et al., 1993) using XhoI and HindIII.
RSA probe: RSA probe is located between exons 3 and 4 of the mouse HPRT locus
and served as internal probe to detect homologous recombination of the U6lox-shA1
targeting vector. RSA probe was excised from pRSA (Bronson et al., 1996) using
BamHI and HindIII.
Quantification of signal intensities was performed using a Storm 860 Molecular
Dynamics scanner and ImageQuant software (Amersham Biosciences).
C 2.1.5 Northern blot analysis
10-20 µg of total RNA in DEPC H2O were diluted in 1 Vol RNA sample buffer (50%
Formamide, 6% Formaldehyde, 10 mg/ml ethidium bromide in 1x RNA Gel Buffer
[20 mM MOPS/NaOH, 5 mM Sodium acetate, 1 mM EDTA, pH 8.0]) and denatured
for 10 min at 65°C. 0.1 Vol of RNA Dye (50% Saccharose, Bromphenolblue) was
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added and the sample was subsequently separated via gel electrophoresis in 1x RNA
Running Buffer (20 mM MOPS/NaOH, 5 mM Sodium acetate, 1 mM EDTA, pH 7.0)
at 40-60 V in a 1.2% RNA agarose gel (1x RNA Gel Buffer, 2 M formaldehyde). The
gel was equilibrated in 10x SSC for 30 min and subsequently transferred onto a
Hybond N+ nylon membrane (Amersham) in 2x SSC by neutral capillary transfer as
described (Sambrook et al., 1989). The membrane was baked at 80°C for 40 min.
Hybridization and probe labeling was performed as described for Southern blot
analysis in part I.
The following probes were used for Northern Blot analyses:
GFP probe: GFP probe comprises the cDNA of EGFP and was excised with XhoI
and NotI from pIRES2-EGFP (Clontech).
GAPDH probe: GAPDH probe comprises part of the mouse GAPDH cDNA and was
excised from pTRI-GAPDH-mouse (Ambion) using SacI.
C 2.1.6 Northern blot analysis of small RNAs
In order to detect RNAs smaller than 100 bp in size, high resolution polyacrylamide
gel electrophoresis (PAGE) was performed under denaturing conditions as described
(Sambrook et al., 1989). In brief, 10-20 µg of total RNA in DEPC H2O were diluted
in 1 Vol RNA Loading Buffer (BD Pharmingen) and denatured for 3 min at 95°C.
Samples were run at 10-15 W on a 10% PA/8M Urea gel (10% PA (BioRad), 0.5x
TBE (Sambrook), 8M Urea, 300µl 10% APS, 40µl TEMED (BioRad)) for 1-2 h. The
gel was stained in 0.5x TBE containing 0.5 µg/ml Ethidium Bromide to detect tRNAs,
which served as loading control. RNA was then transferred onto a Hybond N+ nylon
membrane in 0.5x TBE in a wet transfer chamber. Setup of the transfer was done as
described for Western blots (Sambrook et al., 1989). Transfer was performed at 230
mA for 6-16 h at 4°C. The membrane was subsequently baked at 80°C for 40 min and
hybridized as described for Southern blotting in part I.
Detection of siA1 employed an oligonucleotide-probe specific for the siA1 antisense
strand. The probe was labeled by phosphorylation of the 5’ nucleotide using g-32P-
ATP and T4 Polynucleotide Kinase (NEB) according to the protocol of (Sambrook et
al., 1989). Free nucleotides were removed using a Micro-Spin S-25 column
(Amersham).
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C 2.2 Cell Biology
C 2.2.1 Embryonic stem cell culture
The VNP-VPEinv allele was generated through homologous recombination in IB-10
ES cells (Torres and Kühn, 1997). ES cell culture and transfection was performed as
described in chapter 2.2.1 of part I. Removal of the loxP-flanked neoR selection
marker from targeted ES cells was achieved by transient transfection with 20 mg of
circular Cre-encoding plasmid pIC-Cre (Gu et al., 1993). Two days after transfection,
ES cells were split and replated at a density of 2 x 103 cells per EF-containing 10 cm
tissue culture dish. Colonies were grown in ES cell medium w/o G418 and picked
after 8-10 days. Cells were trypsinized and split into a master and a duplicate EF-
containing 96-well plate. Cells in the duplicate plate were placed under G418
selection (300-400 mg/ml) and G418 sensitive clones were detectable by cell death.
The sensitive clones were then recovered and expanded from the master plate.
The U6lox-shA1 allele was generated through homologous recombination in HM-1
ES cells (Selfridge et al., 1992). ES cell culture and transfection was essentially done
as described. Selection of targeted clones was achieved by addition of Hypoxanthine-
Aminopterin-Thymidine (HAT, Sigma) to ES cell medium starting 2 days after
transfection. HAT resistant ES cell colonies were picked after 8-10 days and
expanded as described in chapter 2.2.1 of part I. Due to its cytotoxic effects,
aminopterin is thought to interfere with proper blastocyst development. HAT-resistent
ES cells were therefore cultured in HAT-free ES cell medium prior to injection.
Transition from HAT+ to HAT- medium required an intermediate passage in medium
that contains Hypoxanthin and Thymidin, but lacks aminopterin (HT, Sigma).
C 2.2.2 Transduction of ES cells with Cre-expressing adenovirus
ES cells were trypsinized as described in chapter 2.2.1 of part I and resuspended at
105 cells/ml in ES cell medium. 5 x 105 cells were plated in one well of a EF-
containing 6 well-plate. 107-108 infectious units of Cre-expressing adenovirus
(Bassing et al., 2002a) were added per well and cells were incubated for 16 h at 37°C.
Cells were washed twice with ES cell medium to eliminate residual virus and
expanded for freezing and analysis.
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C 2.2.3 Flow cytometry and cell sorting
Single cell suspensions were stained with monoclonal antibodies (mAbs) conjugated
to fluorescein isothyocyanate (FITC), phycoerythrin (PE) or allophycocyanin (APC).
Monoclonal antibodies are listed in Table 3 and were either prepared in our laboratory
by C. Uthoff-Hachenberg and B. Hampel or purchased from the indicated suppliers.
Staining for surface expression of NP-binding Ig was performed in two steps: cells
were incubated with NP14-BSA (0.2 ng/ml), washed once with PBS/0.5% BSA and
subsequently stained with S43-APC. Cells were analysed as described in part I.
Specificity Clone     Reference and supplier
anti-CD4 GK1.5-4 Pharmingen
anti-CD5 53-7.3 Parmingen
anti-CD8 53-6.7 Pharmingen
anti-CD19 1D3 Pharmingen
FcBlock 2.4G2 Pharmingen
anti-IgM 1B4B1 eBioscience
anti-NP S43 REF lab-made
B220/ CD45R RA3-6B2 (Coffman, 1982), lab-made
Table II. List of antibodies used for flow cytometry.
Materials and Methods II74
C 2.3 Mouse Experiments
C 2.3.1 Protein transduction of splenic B cells with TAT-NLS-Cre
Single cell suspensions of splenocytes were purified by MACS depletion using anti-
CD43 beads as described by the manufacturer (Miltenyi). The purity of B220+ cells
was greater than 95%. TAT-NLS-Cre transduction was essentially done as described
(Peitz et al., 2002). In brief, B cells were washed twice in serum-free medium
(Hyclone) and incubated at 5x106 cells/ml with the indicated dose of TAT-NLS-Cre
(Peitz et al., 2002) in serum-free medium (Hyclone) for 1 hour at 37 ºC. Cells were
then washed twice in complete medium (Peitz et al., 2002) and cultured at a density of
2x106 cells/ml at 37 ºC and 10% CO2 for 5 days.
C 2.3.2 Induction of Mx-cre transgene expression in vivo
Mx-cre mice were given 3 doses of 400 µg poly(I)*poly(C) (Amersham Biosciences)
via intra-peritoneal injection. Injections were performed on days 0, 3, and 6 and mice
were analyzed 3 days or 6 to 8 weeks thereafter.
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C 3 RESULTS
C 3.1 Unidirectional Cre-mediated genetic inversion in mice using
the mutant loxP pair lox66/lox71
C 3.1.1 Generation of mice carrying a lox66/lox71 flanked VDJ-switch-cassette in
the IgH locus
lox66/lox71-mediated recombination has been demonstrated to be essentially
unidirectional in vitro. In order to test whether this approach can be used to
irreversibly alter gene expression in mice, I generated a lox66/lox71-mediated genetic
switch system that allows the inducible change of the B cell antigen receptor (BCR)
specificity in mice. Change of BCR specificity was chosen as a read-out, since it
allows for the detection of Cre-mediated recombination both on the genomic level by
Southern blot analysis and on the protein level using flow-cytometry (FACS). The
BCR consists of two identical immunoglobulin heavy (IgH) chains, two identical Ig
light (IgL) chains and the signal transducing Iga/Igb heterodimer. The paired variable
domains of IgH and IgL chains (termed VDJ and VJ, respectively) form the antigen
binding sites of the BCR (for review see (Bassing et al., 2002b)) and a change in
either the VDJ or the VJ domain generally results in a change of antigen specificity. I
therefore engineered a lox66/lox71-flanked ‘VDJ-switch cassette’, which consists of
two distinct VDJ gene segments, VNP and VPE (Maruyama et al., 2000) in opposing
transcriptional orientations, and inserted it into the mouse IgH locus by homologous
recombination in ES cells (Figure 2A). Depending on Cre-mediated recombination,
transgenic B cells will express either the VNP or the VPE heavy chain. In
combination with a l1 light chain, the two heavy chains can be distinguished by
surface staining: VNP/Igl1 recognizes 4-hydroxy-3-nitrophenylacetyl-(NP)-
haptenated carrier proteins while VPE/Igl1 binds phycoerythrin (PE). This permits
the detection of lox66/lox71-mediated recombination in single l1+ B cells (~6% of all
splenic B cells).
To generate the targeting vector, the VPE gene segment was PCR amplified from
hybridoma 80A3 (Maruyama et al., 2000) and linked to a 0.5 kb EcoRV/SalI-
fragment containing the VH promoter of the VH3-83 gene (Pelanda et al., 1997). A 2.1
kb BamHI/XhoI-fragment containing the VNP gene segment and its VH promoter
(Sonoda et al., 1997) and an inverted lox71 site 3’ of the VNP segment was ligated to
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the VH3-83-promoter-VPE fragment such that the promoters face away from each
other. This cassette was subsequently fused to the 3’ end of a lox66-flanked TK-neoR
gene (Ferradini et al., 1996) with the downstream lox66 site facing the inverted VPE
segment. An 11 kb XhoI-fragment containing 9 kb of genomic sequence upstream of
DQ52 and the HSV-tk gene (Taki et al., 1993) served as long arm of homology, and a
0.8 kb EcoRI fragment containing part of the JH-Cµ intron (Sonoda et al., 1997) was
used as short arm of homology. The NotI-linearized targeting construct was
transfected into IB10 ES cells (Torres and Kühn, 1997) as described in chapter B
2.2.1. G418 and Gancyclovir double-resistant ES cell colonies were screened for
homologous recombination by Southern blotting using internal probe B (Figure 2B)
and external RH probe (data not shown). The lox66-flanked neoR gene was deleted as
described in chapter 2.2.1 and G418-sensitive clones were verified by Southern blot
analysis (Figure 2B). Two independent ES cell clones that carry the lox66/lox71-
flanked VDJ-switch-cassette without the neoR gene, were injected into CB20
blastocysts. Resulting chimeric male mice were bred to CB20 females for germline
transmission. In order to obtain a second mouse strain that carries the VNPinv-VPE
allele in the germline, VPEinv-VNP/+ mouse mutants were crossed to deleter mice
(Schwenk et al., 1995), which express Cre during early embryogenesis. Two out of
six mice that carried the deleter allele also carried the VNPinv-VPE allele.
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Figure 2. Strategy to switch the IgH variable region exon employing lox66/lox71. (a)
Targeted integration of a VDJ-switch cassette into the IgH locus. BamHI (B) restriction
endonuclease map of the IgH germline JH region (IgH GL), the targeted VDJ switch cassette
before neoR deletion (VPEinv-VNP-neoR) and before (VPEinv-VNP) and after (VNPinv-
VPE) Cre-mediated inversion. Boxes depict D and J exons and the promoter-VDJ exons VPE
and VNP as indicated, arrows symbolize the transcriptional orientation of VNP and VPE. The
oval represents the Eµ enhancer, triangles depict (mutant) loxP sites. Double-headed arrows
indicate BamHI-fragments detected with probe B, fragment sizes are indicated. (b) Southern
blot analysis of IB10 ES cells and a targeted ES cell clone before (VPEinv-VNP-neoR) and
after neoR deletion (VPEinv-VNP). Genomic DNA was digested with BamHI and hybridized
to probe B.
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C 3.1.2 Dose-response analysis of lox66/lox71-mediated inversion in splenic B
cells in vitro
I first determined the efficiency of lox66/lox71-mediated recombination at different
Cre-concentrations in ex vivo isolated splenic B cells from VPEinv-VNP/+ mice. B
cells that carry a WT loxP-flanked VNP gene segment (termed B1-8f, (Lam et al.,
1997)) in the same genomic position served as positive control for recombination. In
the B1-8f allele, the loxP sites are in identical orientation and the VNP segment is
deleted in the presence of Cre. To prevent cell death of primary B cells in culture, B
cells were transgenic for a cDNA encoding the anti-apoptotic Bcl-2 protein (bcl-2tg)
(Strasser et al., 1991). Splenic B cells were incubated for 1h with TAT-NLS-Cre at
different concentrations (Peitz et al., 2002). TAT-NLS-Cre is a fusion protein of a
basic 11-aa peptide derived from HIV-TAT, a nuclear localization signal (NLS) and
Cre. The hydrophobic TAT peptide has been reported to facilitate cellular uptake of
recombinant proteins in vitro and in vivo (Schwarze et al., 1999; Schwarze et al.,
2000). TAT-NLS-Cre-mediated inversion was analyzed five days after Cre
transduction by FACS and by Southern blotting. For FACS analysis, B cells were
stained for NP- and PE-binding (Figure 3A) and inversion frequency was calculated
as the percentage of PE+ cells over the sum of PE+ and NP+ cells (Figure 3C). For
Southern blotting, genomic DNA was digested with BamHI and hybridized to probe
B (see Figure 1). Inversion frequency was calculated as the ratio of VNPinv-VPE
intensity over the sum of VNPinv-VPE- and VPEinv-VNP-intensities (Figure 3D).
Both FACS analysis and Southern blotting yielded comparable inversion frequencies.
To determine the efficiency of WT loxP-mediated deletion, I analyzed B1-8f/+ B cells
for loss of surface IgM expression upon TAT-NLS-Cre transduction (Figure 3B). The
comparison of WT and mutant loxP sites shows a clear difference in recombination
frequencies (Figure 3C). While low doses of TAT-NLS-Cre (≤50µg/ml) induce
recombination in up to ~1/4 of all B cells carrying WT loxP sites, no recombination is
observed with lox66/lox71. To obtain recombination frequencies similar to those of
WT loxP sites, mutant loxP sites have to be exposed to approximately threefold
higher concentrations of TAT-NLS-Cre. To address whether reverse recombination
affects the overall recombination frequency in our system, I incubated B cells that
carry the pre-inverted VNPinv-VPE allele with 200 µg/ml TAT-NLS-Cre (the highest
concentration used in the dose response assay) and analyzed them three days after
transduction. No reverse recombination could be detected by Southern blot analysis
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(Figure 3D). Given the limited sensitivity of this assay, I conclude that <10% of cells
have undergone reverse recombination (see chapter 3.1.3).
Figure 3. Dose response of ex vivo isolated splenic bcl-2tg B cells from VPEinv-VNP/+ or
B1-8f/+ mice to TAT-NLS-Cre. (a) FACS analysis of splenic B cells from VPEinv-VNP/+
bcl-2tg mice to determine lox66/lox71-mediated recombination frequency in vitro. CD43-
MACS-purified B cells were incubated with 0 µg/ml and 100 µg/ml TAT-NLS-Cre and
analyzed five days thereafter. Cells were analyzed for PE- and NP-binding. (b) FACS
analysis of splenic B cells from B1-8f/+ bcl-2tg mice to determine WT loxP mediated
recombination frequency in vitro. Cells were prepared and cultured as described in (a) and
analyzed for IgM expression. (c) Dose response curve of lox66/lox71 and WT loxP mediated
recombination to increasing amounts of TAT-NLS-Cre. Recombination frequencies for
VPEinv-VNP inversion (lox66/lox71, hatched line) and B1-8f deletion (WT loxP, solid line)
were calculated based on FACS analyses performed as in (a) and (b), for details see text. (d)
Southern blot analysis of VNPinv-VPE/+ and VPEinv-VNP/+ bcl-2tg B cells after TAT-
NLS-Cre transduction. Total B cell DNA was digested with BamHI and hybridized with
probe B. Fragments representing VPEinv-VNP, VNPinv-VPE and IgH germline (GL) alleles
are indicated. No lox72/WT loxP-mediated reverse recombination (VPEinv-VNP signal)
could be detected in B cells from VNPinv-VPE/+ mice (left panel). The percentage of cells
that carry the VNPinv-VPE allele as a result of lox66/lox71-mediated recombination is shown
for each lane (right panel); ND, not detected.
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C 3.1.3 lox66/lox71 mediates unidirectional inversion in adult Mx-cre mice
I next analyzed the efficiency of lox66/lox71-mediated recombination in vivo in
combination with the inducible Mx-cre transgene. In Mx-cre mice, Cre expression is
under the control of the Type I Interferon (IFN) inducible Mx1 promoter (Kühn et al.,
1995). Injection of Type I IFN or poly(I)*poly(C), a ds RNA homologue that induces
an endogenous anti-viral Type I IFN response, leads to efficient Cre expression and
subsequent Cre-mediated recombination (Kühn et al., 1995). As potential (counter-)
selection of B cells after Cre-induced change of BCR specificity might obscure the
actual recombination frequency, the analysis was restricted to organs that harbor few
or no BCR+ B cells, such as liver, thymus and bone marrow. I tested lox66/lox71-
mediated recombination in adult VPEinv-VNP/+ Mx-cre mice both three days and
eight weeks after Cre induction by poly(I)*poly(C). To compare the recombination
efficiencies of mutant and WT loxP sites, I also analyzed mice carrying WT loxP-
flanked gene insertions in the same genomic position (Maruyama et al., 2000).
Inversion efficiencies in lymphoid organs, liver and tail were analyzed by Southern
blotting and calculated as the ratio of VNPinv-VPE over IgH GL intensity. In the
liver, ~80% of VPEinv-VNP/+ cells show lox66/lox71-mediated recombination both
three days and eight weeks after Cre induction while no inversion could be detected in
tail tissue at either of the two time points (Figure 4A). These results closely resemble
deletion efficiencies observed with WT loxP sites ((Kühn et al., 1995; Maruyama et
al., 2000) and data not shown). Unlike in liver and tail, recombination frequencies in
thymus and bone marrow increased over time (Figure 4A). Three days after induction,
lox66/lox71-mediated recombination in thymus and bone marrow was three to six
times less efficient than WT loxP-mediated deletion in the same organs (Kühn et al.,
1995; Maruyama et al., 2000) and data not shown). Eight weeks after induction,
however, ~75% of thymocytes and up to 90% of bone marrow cells carried the
inverted allele. This indicates inefficient inversion in B and T lineage cells and bone
marrow macrophages but efficient recombination in hematopoietic stem cells, which
reconstitute bone marrow and thymus within eight weeks after Cre induction. To
determine the extent of lox72/WT loxP-mediated reverse recombination, I analyzed
Mx-cre  mice that carry the pre-inverted VNPinv-VPE allele. No reverse
recombination could be detected eight weeks after injection of poly(I)*poly(C) by
Southern blotting in any of the tissues tested (Figure 4B). Due to the limited
sensitivity of this analysis, I performed quantitative PCR on thymic and liver DNA of
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the same animals using light cycler analysis (Figure 4C). The VPEinv-VNP allele was
amplified using the primer pair LAH-53 and CDR3-PE (see Table I) and TNFR-1 was
amplified as described (Pfeffer et al., 1993) to normalize the individual DNA samples.
No reverse recombination could be detected in the liver of poly(I)*poly(C)-injected
VNPinv-VPE/+ Mx-cre animals, whereas up to 5% of thymocytes have undergone
Cre-mediated reverse recombination. Given that no VPEinv-VNP band could be
detected by Southern blotting, the detection limit of recombination by Southern
blotting was estimated to be between 5 and 10%. Taken together, I conclude that
lox66/lox71-mediated recombination can be efficiently induced in adult Mx-cre mice
and reverse recombination appears to occur only in a minor fraction of hematopoietic
stem cells.
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Figure 4. lox66/lox71-mediated recombination efficiency in Mx-cre mice. (a) Adult
VPEinv-VNP/+ Mx-cre mice were injected with poly(I)*poly(C) and analyzed three days or
eight weeks thereafter. Genomic DNA from lymph nodes (LN), Thymus (Th), bone marrow
(BM), liver (Li) and tail was digested with BamHI and hybridized to probe B. The percentage
of cells that carry the VPEinv-VNP allele in its inverted configuration (VNPinv-VPE) is
shown for each lane. These results are representative for at least two independent
experiments. ND, not detected. (b) Adult VNPinv-VPE/+ Mx-cre mice were injected with
poly(I)*poly(C) and analyzed eight weeks thereafter as described in (a). (c) Quantitative PCR
analysis to detect lox72/WT loxP-mediated reverse recombination in VNPinv-VPE/+ Mx-cre
mice. Thymic and liver DNA was PCR-amplified with primers detecting either the VPEinv-
VNP allele or the TNFR-1 gene to normalize DNA content. The relative abundance of the
VPEinv-VNP PCR product is shown for poly(I)*poly(C)-injected animals and VPEinv-
VNP/+ control mice.
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C 3.1.4 lox66/lox71 mediates cell type-specific unidirectional inversion in CD4-cre mice
To determine lox66/lox71-mediated recombination in mice that express Cre in a cell
type-specific manner, I analyzed VPEinv-VNP/+ mice that carry the CD4-cre
transgene (Wolfer et al., 2001). CD4-cre mice show efficient deletion of WT loxP
flanked gene segments in CD4+/CD8+ double positive (DP) thymocytes and almost
complete deletion in mature T cells (Schmidt-Supprian et al., 2003; Wolfer et al.,
2001). Moreover, the VPEinv-VNP allele is not expressed in T cells and is thus not
subject to potential (counter-) selection upon its inversion. DP thymocytes and splenic
T cells (CD5+/CD19-) from VPEinv-VNP/+ CD4-cre mice were sorted using flow-
cytometry and inversion efficiencies were determined by Southern blotting. CD19+
splenic B cells served as negative control. Recombination was observed in 40% of DP
thymocytes and ~95% of splenic T cells (Figure 5). The higher recombination
efficiency in splenic T cells may be due to the fact that, on average, mature T cells
have been exposed to Cre longer than DP thymocytes, in which CD4-Cre expression
is initiated. The observation that 5% of splenic T cells carry the original VPEinv-VNP
allele could reflect either incomplete inversion or the occurrence of reverse
recombination in maximally 5% of mature T cells.
Figure 5. VPEinv-VNP-inversion in 5 week old VPEinv-VNP/+ CD4-cre mice. Genomic
DNA from FACS-sorted splenic B cells (CD19+), T cells (CD5+) and sorted CD4+/CD8+
thymocytes was digested with BamHI and hybridized to probe B. Inversion frequencies are
indicated for each sample; ND, not detected.
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C 3.2 Inducible RNAi in ES cells
C 3.2.1 Generation of an inducible shRNA expression cassette
Stable gene knock-down by RNAi is dependent on RNA polIII-driven transcription of
shRNAs, which are then processed into functional siRNAs (reviewed in (Tuschl,
2002)). In order to generate a system that allows the inducible expression of shRNAs
and thereby conditional mutagenesis through RNAi, it is therefore imperative to be
able to control RNA polIII-mediated transcription. It has been demonstrated
previously that transcription via RNA polII can be regulated by Cre-mediated
recombination. This approach employs a loxP-flanked transcription STOP cassette,
which is inserted downstream of the RNA polII promoter and efficiently terminates
transcription (Lakso et al., 1992). Upon Cre induction, the STOP cassette is removed
and transcription is resumed. In order to be able to regulate RNA polIII-mediated
transcription in a similar manner, I designed a RNA polIII-specific transcription
termination cassette with the help of C. Kanellopoulou and C. Päper. Termination of
RNA polIII-mediated transcription generally occurs when RNA polIII encounters four
to five consecutive thymidines (referred to as T-stretch) and transcription is aborted
after the second thymidine. Mutational analysis of RNA polIII-mediated transcription
showed that the untranscribed sequence immediately downstream of the T-stretch
may also be involved in transcriptional control (Das et al., 1988). We therefore
generated a U6 STOP sequence that comprises the T-stretch and 190 bp of genomic
DNA downstream of it. An additional T-stretch was inserted next to the endogenous
T-stretch to enhance the efficiency of transcriptional termination. Insertion of the
loxP-flanked STOP cassette between the U6 promoter and the shRNA gene required
several adjustments in order to ensure proper shRNA transcription upon Cre-mediated
deletion of the STOP sequence. Transcriptional initiation at (+1) is crucial for the
precise generation of short RNAs by RNA polIII. Deletion of the STOP cassette will
leave one loxP site at the site of its integration. If the STOP cassette were inserted
after the (+1), this would result in a loxP-shRNA fusion transcript, which may
interfere with proper shRNA processing and siRNA generation. To avoid
transcription of the loxP site, it had to be integrated into the U6 promoter between the
TATA box and (+1). Mutational analyses of the RNA polIII promoter suggest that
this sequence can be altered without affecting the efficiency of RNA polIII-mediated
transcription (Myslinski et al., 2001). However, (+1) is located 26 bp downstream of
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the U6 TATA box and one loxP site comprises 34 bp. Accommodation of a loxP site
in the U6 promoter was achieved as follows: the first 3 bp of the loxP site (ATA)
were integrated into the TATA box and the last 5 bp of the shRNA-proximal loxP site
were exchanged for the first 5 bp of the shRNA coding sequence (Figure 6). Based on
previous results, a 5 bp mutation at the distal end on the inverted repeat is not
expected to dramatically decrease recombination efficiency ((Albert et al., 1995) and
chapter 3.1). Indeed, deletion efficiency of the STOP cassette in vitro was comparable
to that of a WT loxP flanked control DNA segment (Päper, 2002).
The inducible shRNA expression cassette employs the shRNA shA1, which has been
tested previously (Päper, 2002) and is directed against the bcl-2 family members A1a,
A1b and A1d (Hatakeyama et al., 1998; Lin et al., 1993). The cassette is referred to as
U6lox-shA1 and was cloned with the help of C. Päper in three steps: the modified U6
promoter was PCR amplified from the U6 promoter containing plasmid pU6 (Sui et
al., 2002) using primers XbaI-U6 and U6lox-T-RI (see Table I). The 5’ primer
introduces an XbaI site 5’ of the U6 promoter, the 3’ primer replaces the sequence 3’
of the TATA box with a loxP site, two T-stretches and an EcoRI site. The RNA polIII
STOP sequence was PCR amplified from C57BL/6 genomic DNA using primers
U6termRI and U6term1B (see Table I), which introduced a 5’EcoRI site and a 3’
BamHI site. A third fragment consisting of a mutant loxP site fused to shA1 was
generated by oligonucleotide synthesis of two complimentary oligomers, lox-shA1-s
and lox-shA1-as (see Figure 6 for sequence information). The annealed oligomer
contained a 5’ BamHI site and a 3’ HindIII site. The three subfragments were cloned
into a modified pBS-polylinker resulting in an AscI-flanked U6lox-shA1 cassette.
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Figure 6. Inducible shA1 expression construct. Schematic of U6lox-shA1 cassette before
(a) and after (b) Cre-mediated deletion of the STOP sequence. Triangles depict loxP sites,
STOP represents RNA polIII transcription termination sequence including 2 T-stretches,
U6lox stands for the modified, loxP containing U6 promoter. The sequence between the U6
TATA box and the T-stretch is shown in detail for both constructs. loxP sites are underlined,
the shRNA coding sequence is shown in gray. TATA box and T-stretch are depicted in capital
letters. The distance from the 3’ end of the TATA box to the shRNA transcription initiation
site (+1) is 26 bp. Note the overlap between TATA and the 5’ loxP site and the 5 bp mutation
in the shA1-proximal inverted repeat of the 3’ loxP site.
C 3.2.2 Targeted insertion of U6lox-shA1 into HPRT deficient HM1 ES cells
To generate a mouse strain, which allows ubiquitous induction of shA1-mediated
RNAi upon Cre-mediated recombination in a defined genetic locus, the U6lox-shA1
cassette was targeted into the X-linked hypoxanthine phosphoribosyltransferase
(HPRT) locus by homologous recombination in ES cells. This approach takes
advantage of HPRT-deficient HM-1 ES cells (Selfridge et al., 1992), which permit
extremely efficient selection of transgenes inserted into the HPRT locus (Thompson
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et al., 1989). HM-1 ES cells lack the HPRT promoter and exons 1 and 2. Only
reconstitution of the disrupted HPRT locus by gene targeting confers resistance to
HAT selection (Littlefield, 1964). Hence, virtually every HAT-resistant ES cell
colony carries the targeted HPRT allele. A targeting vector that allows the insertion of
transgenes into HM-1 ES cells has been described previously (pMP-8SKB, (Bronson
et al., 1996)). S. Casola in our laboratory generated a modified version of this vector
termed pMP-10, which can be linearized with SwaI, SbfI or SgfI and harbors two
additional unique restriction sites (AscI and PmeI) to insert the transgene of choice.
The U6lox-shA1 cassette was inserted into the AscI restriction site of pMP-10 in the
same transcriptional orientation as the HPRT gene. The targeting vector was
linearized with SwaI and transfected into HM-1 ES cells as described in chapter 2.2.1.
The targeting strategy is shown in Figure 7A. The integrity of HAT-resistant colonies
was confirmed by Southern blotting using a StuI digest and probe RSA (Figure 7B).
Two independent ES cell clones were injected into C57BL/6 blastocysts. Chimeric
mice are currently being bred to multiple cre-transgenic mice for germline
transmission.
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Figure 7. Targeting strategy for U6lox-shA1 insertion into the HPRT locus. (a) Partial
restriction endonuclease maps of the HPRT WT locus, the mutant HM1 locus lacking exons 1
and 2 and the targeted U6lox-shA1 locus; KI, knock in. Roman numbers indicate exons, hI,
human exon 1. Dashed arrows depict fragment sizes as revealed with RSA probe. B, BamHI;
S, StuI. (b) Southern blot analysis to verify homologous recombination. Genomic DNA from
two targeted clones and HM1 ES cells was digested with StuI and hybridized to RSA probe.
Expected fragments before and after homologous recombination are indicated.
C 3.2.3 Generation of (A1)IRES-GFP expression vectors
In order to test whether the U6lox-shA1 cassette is functional, I sought to analyze
Cre-mediated induction of shRNA expression and subsequent knock down of A1 in
ES cells. Since endogenous A1 expression is barely detectable in ES cells, an A1-
encoding transgene was introduced into targeted ES cells. To be able to detect
changes in A1 protein levels by FACS analysis, A1 cDNA was fused to an internal
ribosomal entry site (IRES, ((Jackson et al., 1990; Jang and Wimmer, 1990)) followed
by EGFP cDNA. Expression of this fusion construct results in a bicistronic mRNA
encoding A1 and EGFP, and siA1-mediated mRNA degradation will result in loss of
both A1 and EGFP expression. The coding sequence of the mouse A1d gene was
PCR-amplified from splenic cDNA using primers A1d-X and A1d-B (see Table I),
which introduced a 5’ XhoI site and a 3’ BamHI site. The PCR fragment was then
subcloned into BamHI/XhoI-digested pIRES2-EGFP (Clontech) to generate the A1-
IRES-GFP fusion construct. In order to address sequence specificity of siA1, a
second, mutated A1 expression construct (mutA1-IRES-GFP) was cloned into
pIRES2-EGFP. The mutA1 cDNA contains 6 conservative mutations at the siA1
target site (see Figure 8) and was generated by PCR amplification using primers A1d-
X and mutA1d-B (see Table I). (A1)IRES-GFP constructs were subcloned into the
neoR selectable marker containing expression vector pCXN2 (Niwa et al., 1991). A1-
IRES-GFP, mutA1-IRES-GFP and IRES-GFP fragments were excised from the
respective pIRES2-EGFP vectors using XhoI and NotI and inserted into an XhoI site
3’ of the chicken b-actin promoter of pCXN2. Expression vectors were SalI-
linearized and transfected into U6lox-shA1 ES cells. Stable integrants were selected
with G418 starting 2 days after transfection. Single G418-resistant ES cell colonies
were analyzed for GFP expression in order to confirm expression of the reporter
transgene.
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Figure 8. Schematic of (A1)IRES-GFP expression constructs. Constructs are not drawn to
scale, The mutated siA1 target sequence of construct mutA1-IRES-GFP is shown, gray letters
indicate mutated bases. pA, rabbit b-globin polyA site of the pCXN2 expression vector.
C 3.2.4 Cre-mediated induction of RNAi in ES cells
GFP+ clones of each (A1-)IRES-GFP transgenic ES cell line were transduced with a
Cre expressing adenovirus (Akamatsu et al., 2003; Bassing et al., 2002a; Bassing et
al., 2003) in order to delete the loxP-flanked STOP cassette and induce shRNA
expression. Untransduced cells served as negative control. Seven days after
transduction, ES cells were analyzed for GFP expression by FACS analysis. Only ES
cell clones that were exposed to Cre and carried the perfectly complementary A1-
IRES-GFP transgene showed downregulation of GFP expression, demonstrating
sequence specific and inducible RNAi in U6lox-shA1 ES cells (Figure 9A). The fact
that GFP downregulation occurred only in ~60% of cells likely reflects incomplete
deletion of the STOP cassette. This was confirmed by PCR analysis of genomic DNA
isolated from total cell lysate or subpopulations that were sorted according to GFP
expression levels. Deletion of the STOP cassette was incomplete in the bulk sample
and was exclusively detected in GFPlow cells (Figure 9B). Importantly, similar levels
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of Cre-mediated deletion and concomitant siRNA generation were detected in all Cre-
treated (A1)IRES-GFP ES cell lines, emphasizing the specificity of siA1 for A1-
IRES-GFP mRNA (Figure 9B and C). To determine the extent of mRNA degradation,
(A1)IRES-GFP mRNA levels were analyzed by Northern blotting using a probe
specific for EGFP. The size of the detected mRNA differed depending on the
presence or absence of the A1 cDNA. Detection of GAPDH mRNA served to
normalize for loading differences. GFP mRNA levels were strongly reduced in total
cell lysate and the remaining mRNA is likely to originate from cells that have not
undergone deletion of the STOP cassette. Indeed, when cells were sorted according to
GFP expression, A1-IRES-GFP mRNA was barely detectable in GFPlow cells and
image quantification showed a >10 fold reduction of mRNA when compared to
GFPhigh cells. No mRNA reduction could be observed in untransduced A1-IRES-GFP
transgenic ES cells or in IRES-GFP control samples. These data demonstrate that a
single copy of the U6lox-shA1 cassette mediates efficient, sequence-specific and
tightly regulated suppression of A1 in vitro.
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Figure 9. Sequence-specific Cre-mediated induction of RNAi in ES cells. (A1)IRES-GFP
transgenic U6lox-shA1 KI ES cells were transduced with Cre-expressing adenovirus and
analyzed 7 days thereafter. (a) FACS analysis of GFP expression in transduced (open
histograms) or untransduced ES cells (shaded histograms). The respective (A1)IRES-GFP
transgene is indicated. AV, adenovirus. (b) PCR analysis to detect Cre-mediated deletion of
the polIII STOP cassette. A schematic of the targeted HPRT locus is shown, half-arrows
depict primers hHPRT-pro and HPRT-SAH (see Table I) flanking the inserted U6lox-shA1
cassette. The arrow represents the human HPRT promoter, the gray box depicts human exon
1, the white box mouse exon 2; map is not drawn to scale. PCR results are shown for
transduced and untransduced ES cells transgenic for IRES-GFP (IRES), A1-IRES-GFP (A1)
or mutA1-IRES-GFP (mutA1). A1-IRES-GFP transgenic ES cells were sorted according to
GFP expression levels. DNA from GFPhigh cells and GFPlow cells was subjected to PCR. The
expected sizes for PCR fragments before (U6-STOP-A1) and after deletion of the polIII
STOP cassette (U6-A1) are indicated. The asterisks indicate a fragment resulting from a DNA
hybrid of one U6-STOP-A1 strand and one U6-A1 strand. (c) Northern blot analysis of siA1
expression in transduced and untransduced ES cells carrying the indicated transgene. 20 mg of
total RNA were loaded per lane. Synthetic ds siRNA of identical sequence was loaded as
indicated to estimate siRNA expression levels. (d) Northern blot analysis of (A1)IRES-GFP
mRNA expression levels before and after transduction. 20 mg of total RNA were loaded per
lane. Cre-transduced A1-IRES-GFP transgenic ES cells were sorted according to GFP
expression levels and total RNA from 106 cells was loaded for GFPhigh and GFPlow samples.
Targeted ES cells without IRES-GFP transgene served as negative control (–). Blots were
hybridized to GFP probe. To account for loading differences, blots were stripped and
rehybridized to GAPDH probe. The efficiency of siA1 mediated A1-IRES-GFP knock down
was determined using phosphoimager.
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C 4 DISCUSSION
Both Cre/loxP-mediated conditional mutagenesis and RNA interference provide
powerful means to study gene function in vitro and in vivo. Here, I describe an
extension of the current applicability of Cre/loxP technology as well as the generation
of a novel approach to manipulate the mouse genome, which combines conditional
gene targeting with RNA interference in order to achieve cell-type specific and/or
developmentally regulated gene knock-down in mice.
C 4.1 Unidirectional Cre-mediated gene inversion
Cre/loxP-mediated inversion of genomic DNA segments represents a useful tool to
alter the mouse genome. However, its applicability is hampered by the fact that this
reaction is fully reversible. The mutant loxP pair lox66/lox71 has been shown to
display a favorable forward reaction equilibrium in vitro (Albert et al., 1995; Araki et
al., 1997; Zhang and Lutz, 2002). In order to generate a system that allows
unidirectional gene inversion in mice, I generated a lox66/lox71-flanked switch VDJ-
switch substrate and analyzed its recombination properties both in vitro and in vivo. In
an in vitro dose response analysis, the lox66/lox71 pair has a higher threshold for the
initiation of Cre-mediated recombination and requires two- to threefold higher Cre
concentrations to recombine with the same efficiency as WT loxP sites (Figure 2). No
reverse recombination could be detected in vitro by Southern blotting. Given that the
forward reaction occurred in less than 40% of cells at the maximal dose of TAT-NLS-
Cre and is known to be considerably more efficient than the reverse reaction (Albert
et al., 1995), this is not a surprising result. Sensitivity of Southern blot analysis is,
however, limited and low levels of reverse recombination cannot be excluded.
Toxicity of the TAT-NLS-Cre fusion protein at doses higher than 200 µg/ml made
further increase of the TAT-NLS-Cre concentration impossible.
Since Cre/loxP-mediated recombination is predominantly used for conditional
mutagenesis in vivo and different cre-transgenic mouse strains are likely to display
varying levels of Cre expression, it was important to address the efficiencies of
lox66/lox71-mediated forward and lox72/WT loxP-mediated reverse recombination in
vivo. In mice that carry Cre under the control of either a cell-type specific or an
inducible promoter, lox66/lox71-mediated inversion is highly favored over the
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lox72/WT loxP-mediated reverse reaction. In both cases, the overall recombination
efficiency of mutant loxP sites is slightly reduced when compared to WT loxP sites.
Nevertheless, lox66/lox71-mediated inversion is almost complete in liver and
hematopoietic stem cells of poly(I)*poly(C)-treated Mx-cre animals (Figure 3) and in
mature T cells from CD4-cre mice (Figure 4). Up to 5% of Mx-cre-transgenic
hematopoietic stem cells undergo lox72/WT loxP-mediated reverse recombination
upon poly(I)*poly(C) treatment (Figure 3C) and a similar reversion frequency might
account for the incomplete inversion observed in mature CD4-cre T cells (Figure 4).
This indicates that reverse recombination can occur at low levels and – based on
previous work in plants (Albert et al., 1995) – appears to correlate with the
concentration of Cre. The difference in WT loxP- and lox66/lox71-mediated
recombination frequencies observed in vitro and in vivo is likely to reflect intrinsic
differences between WT and mutant loxP sites. In the case of the latter, Cre/loxP
complex formation might be impaired due to inefficient recruitment of the Cre-
monomer to mutated inverted repeats. Potential differences in accessibility of loxP-
flanked alleles can be ruled out since both WT and mutant loxP sites analyzed in this
study were targeted into the same genomic positions.
Taken together, lox66/lox71-mediated recombination represents an easily applicable
tool for the inducible and essentially unidirectional alteration of the mouse genome by
Cre-mediated gene inversion in vitro and in vivo. Recently, Schnuetgen et al.
(Schnutgen et al., 2003) described a different approach to achieve unidirectional Cre-
mediated gene inversion employing a combination of WT and mutant loxP sites
(lox511), which efficiently recombine with themselves but very inefficiently with
each other (Hoess et al., 1986). This system has been reported to yield a high
inversion frequency in vivo with undetectable levels of reverse recombination.
However, low levels of loxP/lox511 mediated reverse recombination could not be
excluded by the authors, since the detection limit of the PCR approach used to
quantify this event was not determined.
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C 4.2 Cre-mediated induction of RNAi in ES cells
Cre-mediated induction of gene expression generally relies on the removal of a loxP-
flanked STOP cassette, which contains several transcriptional and/or translational
termination elements (Lakso et al., 1992). In the case of RNA polII promoters, the
STOP cassette can be integrated almost anywhere between the promoter and the first
coding exon of the gene of interest. Cre-mediated removal of the STOP cassette
results in one remaining loxP site, which is ideally located in an intron and will
therefore not contribute to the mature mRNA. However, induction of RNAi in vivo is
generally achieved using RNA polIII-mediated shRNA transcription. This
complicates the use of a loxP-flanked STOP cassette for two reasons. First, no
transcription termination cassette has been described for RNA polIII-mediated
transcription. Second, RNA polIII drives transcription of a very specialized set of
genes, which commonly encode structural or catalytic small RNAs and do not contain
intronic or ‘non-coding’ sequence (reviewed in (Schramm and Hernandez, 2002)). As
a consequence thereof, incorporation of a loxP site into RNA polIII transcripts is
expected to interfere with the catalytic function of small RNAs. In the case of shRNA
transcripts, the presence of a loxP site may have unpredictable and possibly harmful
effects on shRNA processing into siRNAs and subsequent induction of RNAi.
Here, I describe the generation of a loxP-flanked RNA polIII-specific STOP cassette
that efficiently inhibits shRNA transcription. The STOP cassette was inserted such
that, upon Cre-mediated recombination, the remaining loxP site is located in the RNA
polIII promoter between the TATA box and the transcription initiation site (+1) and
hence is not incorporated into the shRNA transcript. Cre-mediated deletion of this
STOP cassette initiates gene-specific knock down of a target gene in ES cells by
RNAi. The knock-down efficiency obtained with one copy of the U6lox-shA1
transgene is comparable to knock-down efficiencies that have been observed
previously for both stable and transient RNAi (Brummelkamp et al., 2002; Elbashir et
al., 2001; Song et al., 2003; Sui et al., 2002).
Accommodation of the remaining loxP site upstream of the shRNA transcription
initiation site required the mutation of the last 5 bp of the shRNA-proximal loxP site
(Figure 6). This might limit the general applicability of U6lox-shRNA constructs,
since a similar loxP mutation showed reduced Cre-mediated recombination efficiency
in vivo (see chapter B 3.1). This effect is thought to be due to inefficient recruitment
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of the Cre-monomer to mutated inverted repeats. Given that only one of the two loxP
sites in the U6lox-shA1 cassette is mutated, the reduction in recombination efficiency
is expected to be less than what has been described in chapter B 3.1. Consistent with
this notion, recombination of U6lox-shA1 occurred at levels comparable to WT loxP-
flanked control segments in vitro ((Päper, 2002) and Figure 9). Since different shRNA
sequences will result in different mutations of the shRNA-proximal loxP site and
distinct mutations can result in slightly different recombination properties (Albert et
al., 1995), it is advisable to test the recombination efficiency of every newly
generated U6lox-shRNA cassette in vitro. With this limitation in mind, the system
presented here likely provides a useful tool to induce cell-type specific and/or
developmentally controlled RNAi in vivo.
Recently, Czauderna et al. described an alternative approach to achieve controlled
induction of RNAi in vivo (Czauderna et al., 2003). This approach employs the
tetracylin-regulated bacterial transcriptional repressor tetR, which binds to a specific
sequence element (termed tetO) inserted into the promoter region of the gene of
interest and thereby inhibits its transcription. Release of the repressor can be triggered
by administration of tetracyclin, which binds tetR and leads to a conformational
change incompatible with tetR-tetO interaction (reviewed in (Corbel and Rossi,
2002)). Insertion of a tetR-binding element into the U6 promoter has been
demonstrated to allow tetracyclin-mediated control of shRNA transcription
(Czauderna et al., 2003). While deletion of a transcriptional STOP cassette is an
irreversible event and induction of shRNA transcription is permanent, the tetR system
allows reversible induction of shRNA transcription. The two systems therefore
represent complementary approaches to control RNAi in mice.
Given the vast number of mouse mutants that carry distinct cell-type specific cre
transgenes, Cre-mediated induction of shRNA expression is expected to provide a
useful and widely applicable tool for conditional RNAi in vivo. A list of published
Cre strains can be found on http://www.mshri.on.ca/nagy/cre.htm.
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C 5 SUMMARY
For the last decade, Cre/loxP-mediated conditional mutagenesis has been instrumental
to the study of gene function in mice. Both Cre-mediated deletion and inversion of
loxP-flanked gene segments are widely used to manipulate the mouse genome. While
Cre-mediated deletion is essentially unidirectional, inversion is reversible and
therefore does not support the stable alteration of gene function in cells that
constitutively express Cre. Site-directed mutagenesis yielded a pair of asymmetric
loxP sites (lox66 and lox71) that displays a favorable forward reaction equilibrium in
vitro. Here, I demonstrate that lox66/lox71 mediates efficient and predominantly
unidirectional inversion of a switch substrate that has been targeted into the mouse
genome. lox66/lox71-mediated recombination was two to three times less efficient
than that of a WT loxP pair both in vitro and in vivo. Inversion efficiency was
generally dependent on Cre expression levels and near complete lox66/lox71-
mediated inversion could be observed in vivo using both an inducible and a cell-type
specific cre transgene. Reverse recombination was undetectable in most tissues.
Taken together, lox66/lox71 allows essentially unidirectional gene inversion. Its
efficiency is, however, dependent on the expression level of the cre transgene of
choice.
Over the past few years, RNAi has been introduced as an additional means to
manipulate gene expression. RNAi allows the simultaneous knock-down of several
highly homologous gene products using a single short hairpin RNA (shRNA)
encoding transgene. Here, I combined RNAi with Cre/loxP technology to create a
system that will allow the cell type-specific and/or developmentally regulated
induction of RNAi in mice. In order to control shRNA expression by Cre, I designed a
loxP-flanked transcription termination cassette, which can be removed by Cre-
mediated recombination. A transgene encoding this inducible expression vector has
been integrated into the mouse HPRT locus. Efficient and sequence-specific knock-
down of a target gene was observed with a single copy of this transgene in embryonic
stem cells and this process was strictly dependent on Cre.
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C 6 ZUSAMMENFASSUNG
Konditionale Mutagenese spielt eine zentrale Rolle bei Gen-Funktionsanalysen in
Mäusen. Das Cre/loxP Rekombinationssytem ist das am weitesten verbreitete System,
um Gene zelltyp-spezifisch oder zeitlich abgestimmt zu inaktivieren. Cre
Rekombinase erkennt eine spezielle DNA Sequenz, die als loxP Element bezeichnet
wird. Gen-Segmente, die von loxP Elementen flankiert sind, können, je nach
Orientierung der loxP Elemente, entweder aus dem Genom enfernt oder invertiert
werden. Cre-vermittelte Genentfernung ist nahezu irreversibel. Gen-Inversion,
hingegen, ist umkehrbar solange Cre ausgeprägt wird, und lässt sich nur für
bestimmte Fragestellungen anwenden. Anhand gezielter Mutagenese wurden zwei
mutierte loxP Elemente indetifiziert, die Rekombination vornehmlich in eine
Richtung erlauben (lox66 und lox71). Die vorliegende Arbeit zeigt, dass ein
lox66/lox71-flankiertes, ins Maus Genom integriertes Gen-Segment effizient und
nahzu irreversibel invertiert werden kann. Obwohl die Rekombinatinseffizient von
lox66/lox71 zwei- bis dreifach geringer ist als die unmutierter loxP Elemente, wurde
in Kombination mit einem gewebespezifischen oder einem induzierbaren Cre-
Transgen nahezu komplette Gen-Inversion erreicht. Rückrekombination war in der
Mehrzahl der Gewebe nicht detektierbar. Die Effizienz lox66/lox71-vermittelter
Rekombination hängt allerdings vom Expressionsgrad des gewählten Cre-Transgens
ab.
Während der letzten Jahre hat sich RNA Interferenz (RNAi) als eine Alternative zur
klassischen Genmanipulation etabliert. RNAi ermöglicht die spezifische Degradation
von mRNA durch die Transkription kurzer doppelstrangiger RNA-Moleküle
(shRNAs). In dieser Arbeit wurde RNAi mit dem Cre/loxP Rekombinationssystem
kombiniert, um eine Methode zur induzierbaren RNAi in Mäusen zu etablieren. Um
die Ausprägung von shRNA mittels Cre kontrollieren zu können, wurde ein loxP-
flankiertes DNA-Element entwickelt, das zur vorzeitigen Terminierung von shRNA-
Transkription führt. Dieses Element kann durch Cre-vermittelte Rekombination
entfernt werden. Die induzierbare shRNA Expressionskassette wurde in den HPRT
Genlokus der Maus integriert und vermittelte effiziente, Cre-abhängige RNAi in
embryonalen Stammzellen.
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